Document:

Agreement as to Expense and Liabilities, dated August 8, 2007

 Exhibit 4.7 
 AGREEMENT AS TO EXPENSES AND LIABILITIES 
 AGREEMENT AS TO EXPENSES AND LIABILITIES, dated as of
August 8, 2007, between Fifth Third Bancorp, an Ohio corporation (the “Sponsor”), and Fifth Third Capital Trust V, a Delaware statutory trust (the “Issuer Trust”). 
 WHEREAS, the Issuer Trust intends to issue its Common Securities (the “Common Securities”) to, and acquire Debentures from, the Sponsor and to
issue and sell 7.25% Trust Preferred Securities (the “Trust Preferred Securities”) with such powers, preferences and special rights and restrictions as are set forth in the Amended and Restated Declaration of Trust, dated as of
August 8, 2007, among the Sponsor, as sponsor, Wilmington Trust Company, as Property Trustee and Delaware Trustee, and the Administrative Trustees named therein, as the same may be amended from time to time (the “Amended
Declaration”); 
 WHEREAS, the Sponsor will own all of the Common Securities of the Trust and will issue the Debentures; 
 WHEREAS, terms used but not defined herein have the meanings set forth in the Amended Declaration; 
 NOW, THEREFORE, for good and valid consideration, the receipt and sufficiency of which are hereby acknowledged: 
 ARTICLE I 
 SECTION 1.1.
Guarantee by the Sponsor. Subject to the terms and conditions hereof, the Sponsor hereby irrevocably and unconditionally guarantees to each person or entity to whom the Issuer Trust is now or hereafter becomes indebted or liable (the
“Beneficiaries”) the full payment, when and as due, of any and all Obligations (as hereinafter defined) to such Beneficiaries. As used herein, “Obligations” means any costs, expenses or liabilities of the Issuer Trust, other than
obligations of the Issuer Trust to pay to holders of any Trust Securities the amounts due such holders pursuant to the terms of the Trust Securities. This Agreement is intended to be for the benefit of, and to be enforceable by, all such
Beneficiaries, whether or not such Beneficiaries have received notice hereof. 
 SECTION 1.2. Subordination of Guarantee. The
guarantee and other liabilities and obligations of the Sponsor under this Agreement shall constitute unsecured obligations of the Sponsor and shall rank subordinate and junior in right of payment to all Senior Indebtedness (as defined in the
Indenture) of the Sponsor to the extent and in the manner set forth in the Indenture with respect to the Debentures, and the provisions of Article XIII of the Indenture will apply, mutatis mutandis, to the obligations of the Sponsor
hereunder. The obligations of the Sponsor hereunder do not constitute Senior Indebtedness (as defined in the Indenture) of the Sponsor. 
 SECTION 1.3. Term of Agreement. This Agreement shall terminate and be of no further force and effect upon the dissolution of the Issuer Trust, provided, 

 
however, that this Agreement shall continue to be effective or shall be reinstated, as the case may be, if at any time any holder of Trust Preferred
Securities or any Beneficiary must restore payment of any sums paid under the Trust Preferred Securities, under any Obligation, under the Guarantee Agreement dated as of the date hereof by the Sponsor and Wilmington Trust Company, as guarantee
trustee, or under this Agreement for any reason whatsoever. This Agreement is continuing, irrevocable, unconditional and absolute. 
 SECTION 1.4. Waiver of Notice. The Sponsor hereby waives notice of acceptance of this Agreement and of any Obligation to which it applies or may apply, and the Sponsor hereby waives presentment, demand for payment, protest,
notice of nonpayment, notice of dishonor, notice of redemption and all other notices and demands. 
 SECTION 1.5. No Impairment.
The obligations, covenants, agreements and duties of the Sponsor under this Agreement shall in no way be affected or impaired by reason of the happening from time to time of any of the following: 
 (a) the extension of time for the payment by the Issuer Trust of all or any portion of the Obligations or for the performance of any other obligation
under, arising out of, or in connection with, the Obligations; 
 (b) any failure, omission, delay or lack of diligence on the part of the
Beneficiaries to enforce, assert or exercise any right, privilege, power or remedy conferred on the Beneficiaries with respect to the Obligations or any action on the part of the Issuer Trust granting indulgence or extension of any kind; or

 (c) the voluntary or involuntary liquidation, dissolution, sale of any collateral, receivership, insolvency, bankruptcy, assignment for
the benefit of creditors, reorganization, arrangement, composition or readjustment of debt of, or other similar proceedings affecting, the Issuer Trust or any of the assets of the Issuer Trust (other than the liquidation of the Issuer Trust in
accordance with the terms thereof). 
 There shall be no obligation of the Beneficiaries to give notice to, or obtain the consent of, the Sponsor with
respect to the happening of any of the foregoing. 
 SECTION 1.6. Enforcement. A Beneficiary may enforce this Agreement directly
against the Sponsor and the Sponsor waives any right or remedy to require that any action be brought against the Issuer Trust or any other person or entity before proceeding against the Sponsor. 
 SECTION 1.7. Subrogation. The Sponsor shall be subrogated to all rights (if any) of the Issuer Trust in respect of any amounts paid to the
Beneficiaries by the Sponsor under this Agreement; provided, however, that the Sponsor shall not (except to the extent required by mandatory provisions of law) be entitled to enforce or exercise any rights which it may acquire by way
of subrogation or any indemnity, reimbursement or other agreement, in all cases as a result of payment under this Agreement, if, at the time of any such payment, any amounts are due and unpaid under this Agreement. 
  

 2 

 ARTICLE II 
 SECTION 2.1. Assignment. This Agreement may not be assigned by either party hereto without the consent of the other, and any purported assignment without such consent shall be void. 
 SECTION 2.2. Binding Effect. All guarantees and agreements contained in this Agreement shall bind the successors, assigns, receivers,
trustees and representatives of the Sponsor and shall inure to the benefit of the Beneficiaries. 
 SECTION 2.3. Amendment. So
long as there remains any Beneficiary or any Trust Preferred Securities are outstanding, this Agreement shall not be modified or amended in any manner adverse to such Beneficiary or to the holders of the Trust Preferred Securities without the
consent of such Beneficiary or the holders of the Trust Preferred Securities, as the case may be. 
 SECTION 2.4. Notices. Any
notice, request or other communication required or permitted to be given hereunder shall be given in writing by delivering the same against receipt therefor by facsimile transmission (confirmed by mail), telex or by registered or certified mail,
addressed as follows (and if so given, shall be deemed given when mailed or upon receipt of an answer-back, if sent by telex): 
 If given to
the Sponsor: 
 Fifth Third Bancorp 
 38 Fountain Square Plaza 
 Cincinnati, Ohio 45263 
 Tel: (513) 534-5300 
 Fax: (513) 534-6757 
 Attention: Paul L. Reynolds, Executive Vice President, Secretary and General Counsel 
 If given to the
Issuer Trust: 
 Fifth Third Capital Trust V 
 c/o Wilmington Trust Company 
 Rodney Square North 
 1100 N. Market Street 
 Wilmington, Delaware 19890 
 Tel: (302) 636-6016 
 Fax: (302) 636-4145 
 Attention: Kristin L. Moore, CCTS 
 SECTION 2.5. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. 
  

 3 

 THIS AGREEMENT is executed as of the day and year first above written. 
  

			
	FIFTH THIRD BANCORP
		
	By:	 	 /s/ Mahesh Sankaran

	Name:	 	Mahesh Sankaran
	Title:	 	Senior Vice President and Treasurer
	
	FIFTH THIRD CAPITAL TRUST V
		
	By:	 	 /s/ Mahesh Sankaran

	Name:	 	Mahesh Sankaran
		 	Administrative TrusteeBill of Sale and Assignment Agreement

 Exhibit 10.1 
  

 BILL OF SALE AND ASSIGNMENT AGREEMENT 
 DATED AS OF AUGUST 7, 2007 
 BETWEEN 
 COOPERSURGICAL, INC. 
 AND ATRICURE, INC.

  

 TABLE OF CONTENTS 
  

					
	 	  	 	  	Page
	 Section 1.
	  	Defined Terms.	  	1
			
	 Section 2.
	  	Sale and Delivery of Assets.	  	1
			
	 Section 3.
	  	Instruments of Conveyance and Transfer, etc.	  	4
			
	 Section 4.
	  	Excluded Assets.	  	4
			
	 Section 5.
	  	Assumed Liabilities.	  	4
			
	 Section 6.
	  	Trademark License.	  	5
			
	 Section 7.
	  	Warranty and Replacement Service.	  	8
			
	 Section 8.
	  	Manufacturing Equipment.	  	9
			
	 Section 9.
	  	Damage and Insurance.	  	10
			
	 Section 10.
	  	Purchase Price.	  	10
			
	 Section 11.
	  	Non Compete	  	11
			
	 Section 12.
	  	Access; Manufacturing Know-How.	  	11
			
	 Section 13.
	  	Representations, Warranties and Covenants of Cooper.	  	12
			
	 Section 14.
	  	Representation and Warranties of AtriCure.	  	14
			
	 Section 15.
	  	Indemnification.	  	15
			
	 Section 16.
	  	Taking of Necessary Action; Further Assurances.	  	18
			
	 Section 17.
	  	Confidentiality.	  	18
			
	 Section 18.
	  	Complaints and Recalls.	  	20
			
	 Section 19.
	  	Notices.	  	20
			
	 Section 20.
	  	Governing Law; Waiver of Jury Trial.	  	21
			
	 Section 21.
	  	Counterparts; Facsimile and Electronic Signatures.	  	22
			
	 Section 22.
	  	Successors and Assigns.	  	22
			
	 Section 23.
	  	Amendment, Waiver; Breach.	  	22
			
	 Section 24.
	  	Construction.	  	23

  

 2 

 BILL OF SALE AND ASSIGNMENT AGREEMENT dated as of August 7, 2007 (this
“AGREEMENT”), between COOPERSURGICAL, INC., a Delaware corporation (“Cooper”), and ATRICURE, INC., a Delaware corporation (“AtriCure”). 
 Cooper owns the Frigitronics® CCS-200 product line (the “PRODUCT LINE”) for use in cardiovascular cryosurgery consisting of the CCS-200 cardiovascular cryosurgery unit
item P3050 (the “CONSOLE”) and CCS-200 cardiovascular probes (the “PROBES” and, together with the CONSOLE, the “PRODUCTS”) and other assets related to the PRODUCTS. The development, manufacture,
sales and distribution of the PRODUCTS is referred to herein as the “BUSINESS.” AtriCure wishes to acquire and Cooper wishes to sell and assign to AtriCure all of Cooper’s right, title and interest in and to the PRODUCT LINE
(the “SALE”). 
 Pursuant to the terms of this Agreement, Cooper will continue to manufacture, supply and deliver the
PRODUCTS to AtriCure (the “MANUFACTURING SERVICES”) for a period of time, and subsequent thereto Cooper will deliver to AtriCure remaining inventory and machinery and equipment as provided in this Agreement. 
 ACCORDINGLY, in consideration of the mutual covenants and obligations set forth herein and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties hereby agree as follows: 
 Section 1. Defined Terms. 
 Certain capitalized terms used in this Agreement are defined on Annex I attached hereto. 
 Section 2. Sale and Delivery of Assets. 
 (a) On the terms and subject to the conditions contained in this Agreement, Cooper hereby sells, transfers, conveys and irrevocably assigns to AtriCure, free and clear of all Encumbrances, and AtriCure hereby purchases and acquires from
Cooper, all of Cooper’s right, title and interest in, to and under the following assets, properties, interests in properties and rights of Cooper, whether tangible or intangible, which are solely related to the Product Line, as the same exists
on the date hereof (each of the following to constitute a “PURCHASED ASSET”): 
 (i) the PRODUCTS listed on Schedule A
of this Agreement; 
 (ii) all manufacturing, production, maintenance, packaging and/or testing machinery and equipment, tools, dies, jigs,
patterns, gauges (together with all spare and maintenance parts) solely used in or solely relating to the manufacture of the PRODUCTS, including those listed on Schedule B of this Agreement (collectively, “MACHINERY AND EQUIPMENT”);

 (iii) all inventory, raw materials, components, work-in-progress, spare parts, packaging materials and
stores and supplies relating solely to the PRODUCT LINE, including those listed on Schedule C of this Agreement (collectively, the “INVENTORY”); 
 (iv) Intentionally Deleted. 
 (v) the books, records and files (including computer files and
electronic media) correspondence, supplies and customer and account records and information, sales records and instruction and service manuals and bulletins, and blue prints, drawings and other technical papers and specifications, records and files
exclusively concerning the PRODUCT LINE including those related to the FDA and other GOVERNMENTAL ENTITIES in the United States and in other jurisdictions, quality control records, training materials, product bulletins, product information booklets,
inventory records, sales, customer, vendor and purchase history (including, as previously delivered to Atricure, a complete list of all customers that have purchased PRODUCTS during the last five years, the type of PRODUCTS purchased by such
customers and the address to which Cooper shipped such PRODUCTS) related solely to the PRODUCT LINE (i.e., excluding all information of Cooper relating to any other products, lines of business or operations) in computer and other formats, all
technical manuals and other documents necessary to the use of the PRODUCTS including the production of the PRODUCTS by Cooper and the conduct of business by Cooper related to the PRODUCT LINE (Cooper having the right to retain copies or to retain
originals and give AtriCure copies) (collectively, the “BOOKS AND RECORDS”); 
 (vi) subject to Section 3(b), all
warranties and guarantees received from vendors, suppliers and manufacturers of the PRODUCTS and raw materials and components thereof, including those listed on Schedule D (the “Assigned Warranties”); 
 (vii) all transferable federal, state, local and foreign governmental registrations, approvals and licenses relating solely to the PRODUCTS, including
those listed on Schedule E of this Agreement (the “Transferable Approvals”); and 
 (viii) all purchase orders, forms, labels,
shipping materials, catalogs, brochures, art works, photographs and advertising, sales and promotional materials relating solely to the PRODUCT LINE, as the same shall exist on the date hereof. 
 (b) Transfer of title and delivery: 
 (i)
Cooper is hereby transferring title to all PURCHASED ASSETS to AtriCure on the date hereof; 
 (ii) Intentionally Deleted.

 (iii) During the MANUFACTURING TERM Cooper shall retain physical possession of the PURCHASED ASSETS specified in Sections 2(a)(ii),
2(a)(iii), and 2(a)(viii) in order to perform MANUFACTURING SERVICES for AtriCure. Cooper will deliver these PURCHASED ASSETS (including any and all then existing component and sub-assembly INVENTORY) to AtriCure at AtriCure’s expense promptly
after the completion of the MANUFACTURING SERVICES (within 15 days). 
  

 2 

 (iv) Prior to or during the Manufacturing Term, Cooper shall deliver to Atricure the PURCHASED ASSETS
specified in Section 2(a)(v). 
 (v) Without limiting Section 9(d), risk of loss of the PURCHASED ASSETS listed in 2(a)(ii) and
(iii) shall pass to AtriCure on the date of this Agreement. Risk of loss of any other physical Purchased Assets shall pass to AtriCure at the time the assets are delivered to AtriCure as provided in Section 2(b). 
 (c) MANUFACTURING SERVICES: 
 (i) During the
MANUFACTURING TERM, Cooper shall manufacture, supply and deliver the CONSOLES and PROBES to AtriCure as set forth below. The CONSOLES and the PROBES shall be manufactured by Cooper in the same manner as they were manufactured by Cooper before
Closing and shall, accordingly, be substantially identical to those heretofore manufactured for AtriCure. Cooper shall supply PRODUCTS exclusively to AtriCure and Cooper shall not manufacture or sell any PRODUCTS to any other Person: 
 (A) Cooper shall manufacture and supply for AtriCure a total of twenty (20) CONSOLES. Beginning in September 2007, CONSOLES shall be delivered to
AtriCure at the rate of 5 CONSOLES per month (each such monthly shipment referred to as a “CONSOLE DELIVERY”) in accordance with Schedule G hereto. 
 (B) Cooper shall manufacture and supply for AtriCure a total of forty (40) 3011 PROBES (each a “3011 PROBE”). Beginning in
September 2007, the 3011 PROBES shall be delivered to AtriCure at the rate of ten (10) 3011 PROBES per month (each such monthly shipment referred to as a “PROBE DELIVERY”) in accordance with Schedule H hereto.

 (ii) Products shipped under sections 2(c)(i)(A) and (B) shall be shipped F.O.B. Cooper’s Facility. The shipper shall be
designated by AtriCure or, in the absence of such designation, by Cooper; 
 (d) Packaging. Cooper shall package and label Products
and Product literature in the same manner as it has prior to Closing packaged and labeled Products and Product literature sold to AtriCure. AtriCure may, however, change by reasonable notice to Cooper during the Manufacturing Term specifications for
packaging and labels for Products and identifying logos on Product literature. AtriCure shall pay to Cooper the reasonable out-of-pocket cost of any changes made by AtriCure from Cooper’s existing packaging, labels and Product literature and
any additional reasonable out-of-pocket cost incurred by Cooper to produce the changed packaging, labels and Product literature requested by AtriCure. Cooper shall bill AtriCure for such costs and AtriCure shall pay the amount billed within 30 days
after receipt of the bill. 
 (e) After the end of the MANUFACTURING TERM, AtriCure will be responsible for acquiring raw material and
component inventory for any PRODUCTS that it desires in excess of the PRODUCTS Cooper is to deliver to AtriCure pursuant to Section 2(c). 
  

 3 

 Section 3. Instruments of Conveyance and Transfer, etc. 
 (a) Cooper shall execute and deliver such instruments and documents, take such steps and otherwise cooperate as AtriCure may reasonably request to
transfer title to the PURCHASED ASSETS to AtriCure and to put AtriCure in possession and operating control of the PURCHASED ASSETS at the times provided for in this Agreement. 
 (b) Anything contained in this Agreement to the contrary notwithstanding, this Agreement shall not constitute an agreement or an attempted agreement to
sell, transfer or assign any Assigned Warranty (or any claim or right or any benefit arising thereunder or resulting therefrom), if the attempted transfer or assignment thereof, without the consent of any other party thereto, would constitute a
breach thereof or in any way adversely affect the rights of AtriCure or Cooper. During the Manufacturing Term, Cooper shall use its commercially reasonable efforts to obtain the consent of the other party to any Assigned Warranty to the transfer or
assignment thereof to AtriCure in all cases in which such consent is required for the transfer or assignment of any such Assigned Warranty. Pending the receipt of any such consent, Cooper shall use its commercially reasonable efforts to provide for
AtriCure the benefits of such Assigned Warranty, including (a) adherence to reasonable procedures established by Atricure for the immediate transfer to AtriCure of any payments, funds or other benefits or assets received by Cooper thereunder
and (b) enforcement for the benefit of AtriCure of any and all rights of Cooper thereunder against the other party or parties thereto arising out of the breach or cancellation thereof by such other party or parties or otherwise. 
 Section 4. Excluded Assets. 
 For the avoidance of doubt, except as set forth in this Agreement, Cooper is retaining the
FRIGITRONICS® trademark (the “LICENSED MARK”) and rights, if any, to CCS-200 to identify Products in the Product Line and any and all assets that do not solely relate to the PRODUCT LINE or the PRODUCTS, including assets
relating to the Frigitronics® CE-2000 product line for use in ophthalmology. Cooper is also retaining all accounts receivable,
cash deposits, prepaid assets, phone numbers, websites and books of original entry related to the PRODUCT LINE, rights to refunds from suppliers to Cooper of inventory of the PRODUCTS and components thereof and assets that relate both to the
PRODUCTS or the PRODUCT LINE and to other products manufactured, sold or distributed by Cooper. 
 Section 5. Assumed Liabilities.

 (a) On the terms and subject to the conditions contained in this Agreement, upon termination of the MANUFACTURING TERM, AtriCure shall
perform all warranty repair and replacement services (“WARRANTY SERVICES”) that Cooper is obligated to perform in respect of all PRODUCTS sold by Cooper prior to the Closing Date. 
 (b) Except as provided herein, AtriCure shall assume no other LIABILITY of Cooper, including any liability for personal injury arising from the
manufacture or sale of Products by Cooper prior to the Closing Date (the “EXCLUDED LIABILITIES”). 
  

 4 

 Section 6. Trademark License. 
 (a) Cooper hereby grants to AtriCure a fully paid up, irrevocable, royalty-free, non-transferable, limited worldwide license (the “LICENSE”) to
utilize only for a period of no more than four years from the Manufacturing Termination Date and not thereafter the LICENSED MARK and the letters and numbers CCS-200 solely in connection with the promotion, manufacture and sale of the Enhanced
Product Line. The License is exclusive (including as to Cooper) solely in the field of cardiac cryosurgery. The License does not permit AtriCure to use the Licensed Mark or CCS-200 in any other field or in any manner not expressly specified for in
the License. The Licensed Mark will continue to be used by Cooper, and Cooper may also permit others to use the Licensed Mark, for products and services (including cryosurgery products) other than those products and services used for cardiac
cryosurgery. Cooper may also continue to use CCS-200 for products and services other than products and services used for cardiac cryosurgery. The License is granted subject to the terms and conditions set forth in this Agreement and subject to
Cooper’s quality control described in (d) below. 
 (b) The LICENSED MARK shall always be used as a trademark. 
 (c) AtriCure shall not: 
 (i) sublicense or
transfer the LICENSED MARK or CCS-200 or variations thereof to any third party or permit any Person other than AtriCure to use the Licensed Mark or CCS-200 except on the Enhanced Product Line and material such as instructional and marketing material
connected with the Enhanced Product Line that is supplied by AtriCure and that otherwise conforms with the requirements of this Section 6; 
 (ii) attempt to register any mark including or consisting of the LICENSED MARK or CCS-200, or any variation thereof, or anything confusingly similar thereto as a trademark, service mark, business name, or domain name; 
 (iii) use the Licensed Mark or CCS-200 independent of the word “AtriCure” and, when so used, keep the Licensed Mark and CCS-200 smaller than
AtriCure as provided in (g) below; or 
 (iv) use the Licensed Mark or CCS-200 in any manner that would jeopardize Cooper’s rights
in the LICENSED MARK or CCS-200. 
 (d) Atricure shall use the LICENSED MARK and CCS-200 only as provided in this Agreement and in a format
and manner consistent with the quality and prestige associated with the LICENSED MARK. AtriCure may use the LICENSED MARK and CCS-200 only so long as the quality of the products in the Enhanced Product Line that are identified with the Licensed Mark
and CCS-200 is at least equal to the quality of such goods in workmanship and materials rendered or performed prior to the date hereof by Cooper and only so long as the other materials related to such products on which AtriCure may use the Licensed
Mark and CCS-200 are consistent with such quality. The manufacturing, packaging, storage, shipment, marketing, promotion, advertising and distribution by AtriCure of all such products bearing the LICENSED MARK and CCS-200 shall be in accordance

  

 5 

 
with all applicable federal, state and local laws and regulations. Cooper may at any time during the term of the License on reasonable notice to AtriCure
inspect the facilities of AtriCure in which the products are manufactured and the materials on which the Licensed Mark and CCS-200 appear to monitor the quality of the products and other materials on which the Licensed Mark and CCS-200 appear, and
AtriCure shall provide Cooper with such access to such facilities and copies of such materials. 
 (e) In the event AtriCure learns of any
infringement of Atricure’s rights in the Licensed Mark or CCS-200, it shall promptly notify Cooper in writing of such unauthorized use, and Cooper shall do likewise (the date of any such notification being the “Infringement Notice
Date”). 
 (f) AtriCure shall notify Cooper if Atricure has ceased using the Licensed Mark and CCS-200 at any time prior to the fourth
anniversary of the Manufacturing Termination Date. The License shall terminate on the earlier of the fourth anniversary of the Manufacturing Termination Date or the date that AtriCure notifies Cooper that AtriCure has ceased using the Licensed Mark
and CCS-200. Cooper may also terminate the LICENSE, effective immediately upon receipt of notice, if any of the following events occur: (i) AtriCure goes into liquidation, is the subject of a case in bankruptcy, is declared insolvent by a court
of competent jurisdiction, or has assigned its assets for the benefit of creditors or (ii) AtriCure breaches any of the provisions set forth in this Section 6 of this Agreement and fails to cure the same within 30 days after receipt of
notice to cure from Cooper. Upon termination of the LICENSE, all rights granted to AtriCure hereunder shall revert to Cooper, and AtriCure shall immediately either destroy all products and other materials containing the LICENSED MARK and CCS-200, or
any related mark, or mark confusingly similar thereto. AtriCure shall at Cooper’s request certify to Cooper that such destruction has occurred. 
 (g) All products in the Enhanced Product Line manufactured and sold by AtriCure after the termination of the MANUFACTURING TERM that include the Licensed Mark shall be marked with both the Licensed Mark and AtriCure
names, the Licensed Mark and CCS-200 in all cases to be displayed at a size and prominence of 50 percent or less of the respective size and prominence of the AtriCure name. All other materials used by AtriCure that relate to such products, including
written materials and materials transmitted electronically or through other media, that include the Licensed Mark or CCS-200 shall include both the Licensed Mark (and CCS-200) and AtriCure, the Licensed Mark and CCS-200 in all cases to be displayed
at a size and prominence of 50 percent or less of the size and prominence of the AtriCure name. AtriCure shall not be required to modify any inventory manufactured by Cooper under this Agreement to comply with the foregoing. 
 (h) In the event and to the extent that the manufacture, promotion or sale of the products in the Enhanced Product Line by AtriCure in accordance with
the terms of this Agreement would infringe any patent or intellectual property other than the LICENSED MARK or CCS-200 owned or controlled by Cooper as of the Closing Date, Cooper hereby irrevocably waives and releases each and any claim or cause of
action arising out of such infringement. 
  

 6 

 (i) The following terms shall govern claims relating to infringement referred to in Section 6(e)
above: 
 (i) Bringing of Suit. In the event of any such suspected infringement: 
 (A) First Right. Cooper shall have the first right to file suit against any such allegedly infringing party. 
 (B) Secondary Right. In the event that Cooper fails to commence, within ninety (90) days after the Infringement Notice Date, a lawsuit
regarding such alleged infringement, Atricure shall have the right to prosecute such a lawsuit. 
 (ii) Cooperation; Joinder.

 (A) Control. The party undertaking the lawsuit under Section 6(i)(i) shall have the right to control such action. 

(B) Cooperation. Each party shall cooperate, in all reasonable respects, with the other party in any lawsuit brought by the other party under
Section 6(i)(i). 
 (C) Information. The controlling party shall, on a continuous basis, (i) keep the other party apprised
of all material aspects thereof and consult with the other party concerning the conduct thereof; and (ii) forward to the other party any and all material documents (including pleadings, interrogatories, deposition transcripts and
communications), relating to the lawsuit, as may be requested by the other party (except to the extent that the same would involve a waiver of the attorney-client privilege with respect to the material so requested). 
 (D) Counsel. The other party shall have the right, at its expense, to employ separate counsel and fully participate in (but not control) the
conduct of the lawsuit. 
 (E) Compulsory Joinder. The controlling party shall have the right to cause the other party to join (i.e.,
become a party to) any lawsuit contemplated by Section 6(i)(i) provided that (i) the joinder of the other party is mandatory in order for the claims being asserted by the controlling party to proceed under applicable Law and (ii) the
controlling party shall promptly reimburse the party so joined for all its reasonable and documented out-of-pocket costs incurred in connection with participating as a party to such lawsuit. 
 (F) Voluntary Joinder. The non-controlling party shall, in addition, have the right to join any lawsuit contemplated by Section 6(i)(i) as a
party thereto, and to participate accordingly, at its own expense. 
 (iii) Settlement. The party controlling any lawsuit described in
Section 6(i)(i) may not settle such lawsuit without the express written consent of the non-controlling party, such consent not to be unreasonably withheld or delayed. 
  

 7 

 (iv) Damages. 
 (A) Definitions. For purposes of this Agreement: 
 (i) “Infringement Costs” shall mean any
out-of-pocket expenses (including attorneys’ fees) incurred by the controlling party in connection with any action referred to in Section 6(i)(i); 
 (ii) “Infringement Damages” shall mean any amounts representing compensation for lost sales, royalties or profits, or any other damages, incurred by a party as a result of infringement of its rights.

 (B) Allocation. Unless otherwise mutually agreed by the parties, all monies recovered upon the final judgment or settlement of any
lawsuit described in Section 6(i)(i) shall be allocated: 
 (i) first, to reimburse the controlling party for its Infringement Costs
relating to the action; 
 (ii) second, to the parties to the action (i.e., Cooper and/or Atricure, as the case may be), on a pro rata basis
(if there shall have been more than one such party to the action) to the extent of (and with such proration based upon) any Infringement Damages incurred by them as a result of the infringement (provided, however, that a party who shall have been
joined in the action only pursuant to Section 6(i)(i)(E) shall not be entitled to share in Infringement Damages); and 
 (iii) third,
to the controlling party. 
 Section 7. Warranty and Replacement Service. 
 (a) Cooper shall provide during the MANUFACTURING TERM and not thereafter WARRANTY SERVICES for PRODUCTS, whether sold by Cooper prior to the date of this
Agreement (including those sold to Atricure) or by AtriCure thereafter (including those purchased from Cooper). Cooper expressly warrants that all PRODUCTS supplied by it under this Agreement shall be substantially identical to, the PRODUCTS
purchased by Atricure from Cooper prior to the Closing Date, (ii) manufactured in accordance with all applicable Laws, (iii) shall be merchantable, fit for the purpose for which they were designed and (iv) free from defects in
materials and workmanship. The foregoing warranty (the “PRODUCT WARRANTY”) shall be effective for the same period of time as the warranty provided by Cooper to AtriCure for Products sold by Cooper to AtriCure prior to the date of
this Agreement. THE WARRANTIES IN THIS SECTION 7(a) ARE IN LIEU OF, AND EXCLUDE, ALL OTHER WARRANTIES, EXPRESS OR IMPLIED, ORAL OR WRITTEN. THE OBLIGATION TO REPAIR OR REPLACE PROVIDED FOR IN SECTION 7(b) IS THE SOLE REMEDY FOR BREACH OF THE PRODUCT
WARRANTY UNDER THIS AGREEMENT. COOPER WILL NOT IN ANY EVENT UNDER THIS WARRANTY BE LIABLE FOR ANY SPECIAL, INCIDENTAL, CONSEQUENTIAL OR INDIRECT DAMAGES OF ANY KIND, INCLUDING ECONOMIC DAMAGE OR DAMAGE TO PROPERTY. IN NO EVENT SHALL THE
RESPONSIBILITY AND LIABILITY OF COOPER IN CONNECTION WITH A BREACH OF THE PRODUCT WARRANTY BE GREATER THAN COOPER’S DISTRIBUTOR PRICE FOR THE PRODUCTS. 
  

 8 

 (b) Subject to Section 7(d), AtriCure shall notify Cooper in writing of any nonconforming PRODUCT
received from any AtriCure customer or discovered by AtriCure and shall return it to Cooper F.O.B. AtriCure’s or customer’s facility in the United States after receipt of a return authorization (“RA”) from Cooper. Cooper
shall not unreasonably withhold issuance of an RA. Cooper shall replace or repair the non-conforming unit as soon as practicable (but in any event within 30 days after Cooper’s receipt of such unit) and shall return the replaced PRODUCT to or
as directed by AtriCure F.O.B. destination, at the expense of Cooper. 
 (c) At the request of AtriCure, Cooper shall provide during the
MANUFACTURING TERM non-warranty repair service for PRODUCTS which are manufactured by Cooper at Cooper’s standard charges for repairs. 
 (d) Notwithstanding b and c. of this Section 7, Cooper’s obligations under this Agreement to provide WARRANTY SERVICES shall cease with respect to PRODUCTS at the end of the MANUFACTURING TERM and thereafter AtriCure
shall provide all Warranty Services for products in the Enhanced Product Line, including Warranty Services assumed by AtriCure under Section 5(a). 
 Section 8. Manufacturing Equipment. 
 (a) Until Cooper has completed the Manufacturing Services, AtriCure shall
permit Cooper to use the manufacturing equipment which belongs to AtriCure and was purchased hereunder (the “Manufacturing Equipment”) for the supply of Products to AtriCure under this Agreement. THE MANUFACTURING EQUIPMENT IS BEING USED
BY COOPER “AS IS” WITH ALL FAULTS AND WITHOUT WARRANTY OF ANY KIND FROM ATRICURE. Cooper shall use the Manufacturing Equipment in accordance with its pre-Closing practices. Cooper shall, at its own expense, maintain such equipment in
working condition and in good repair, including providing replacement parts, which shall become part of the Manufacturing Equipment. After the completion of the Manufacturing Services, Cooper shall deliver or cause to be delivered to or at the
direction of AtriCure , the Manufacturing Equipment in working condition and good repair. Delivery shall be F.O.B. Cooper’s Facility. Cooper shall, at AtriCure’s expense, pack the Manufacturing Equipment for shipment. AtriCure shall pay
Cooper the reasonable amount billed for such packing within 15 days after being invoiced therefor. 
 (b) Cooper shall notify AtriCure if an
item of Manufacturing Equipment cannot be repaired, but must, in Cooper’s judgment, be replaced to continue to operate. Cooper shall provide AtriCure with information reasonably required by AtriCure to determine if AtriCure wishes to replace
such item at AtriCure’s expense, including the price, delivery schedule of replacement equipment and any alternatives to replacement of the equipment which may be available in order for Cooper to maintain its supply to AtriCure of Product under
this Agreement; provided, however, that in the event that the need for repair arose from Cooper’s negligence or other wrongful conduct (including failure to maintain the same in accordance 

  

 9 

 
with this Agreement), any repair or replacement shall be at Cooper’s expense. Cooper shall comply with AtriCure’s instructions concerning such
item. Any such equipment replaced at AtriCure’s expense (or, under the conditions described above, at Cooper’s expense) shall become Manufacturing Equipment. 
 Section 9. Damage and Insurance. 
 (a) Cooper shall promptly notify AtriCure if the
facility of Cooper in Trumbull, Connecticut which the Products are manufactured (“Cooper Facility”) is damaged in any manner which will adversely affect Cooper’s ability to manufacture Products pursuant to this Agreement. Such notice
will include a description of the damage, the estimated impact of the damage on Cooper’s ability to so manufacture Products and the estimated time to repair the damage sufficiently to enable Cooper to perform its obligations under this
Agreement. 
 (b) AtriCure shall insure the Manufacturing Equipment held by Cooper at the Cooper Facility and the inventory of Products
purchased by AtriCure under this Agreement against loss or damage by fire, lightning and other casualty. 
 (c) Cooper shall insure
Cooper’s property in the Cooper Facility against loss or damage by fire, lightning and other casualty and the Cooper employees performing the Manufacturing Services against risks normally insured against by a Person conducting the same business
as Cooper, in each case consistent with the practices of Cooper prior to the Closing. 
 (d) With respect to all items of tangible personal
property (other than the Manufacturing Equipment) possession of which is maintained by Cooper pursuant to this Agreement subsequent to the Closing Date, Cooper shall maintain such personal property in the same condition as it was in on the date of
this Agreement (normal wear and tear excepted). 
 Section 10. Purchase Price. 
 (a) AtriCure, in consideration for the sale of the PURCHASED ASSETS and the License granted to AtriCure hereunder, shall pay to Cooper $3,661,536 (the
“Purchase Price”). AtriCure shall pay to Cooper $3,244,244 of that amount in immediately available funds on the date hereof (the “INITIAL PAYMENT”) and, on the third Business Day following the Manufacturing Termination
Date, AtriCure shall pay to Cooper in immediately available funds the balance of US $417,292 (the “DEFERRED PAYMENT)”. The DEFERRED PAYMENT shall be evidenced by an interest bearing Promissory Note in the form attached hereto
as Exhibit 1. 
 (b) The PURCHASE PRICE shall be allocated to the PURCHASED ASSETS in accordance with a reasonable allocation prepared
by Cooper and delivered to AtriCure within ninety (90) days of the Closing Date (the “STATEMENT OF ALLOCATION”). AtriCure shall not take a position on any tax return or with any tax authority that is inconsistent with the
STATEMENT OF ALLOCATION. Within ten (10) days of the receipt by AtriCure of the STATEMENT OF ALLOCATION, AtriCure shall, subject to the foregoing: 
 (i) complete and execute Forms 8594 Asset Acquisition Statement Under Section 1060 of the Internal Revenue Code of 1986, as amended, consistent with the STATEMENT OF ALLOCATION; and 
  

 10 

 (ii) deliver copies of such forms to Cooper. 
 Cooper and AtriCure shall each file a copy of the above-referenced forms with its respective tax returns for the period which includes the Closing date.

 (c) For purposes of this Agreement, the termination of the Manufacturing Term (the date of such termination being the “Manufacturing
Termination Date”) shall be deemed to have occurred on that date on which all of the following shall have occurred: 
 (i) completion, in
all material respects, of the MANUFACTURING SERVICES; and 
 (ii) delivery to Atricure of all material tangible personal property included in
the PURCHASED ASSETS. 
 Section 11. Non Compete 
 AtriCure and Cooper shall each execute on the date hereof a non-competition agreement substantially in the form of Exhibit 2 hereto (the “NON-COMPETITION AGREEMENT”). 
 Section 12. Access; Manufacturing Know-How. 
 (a) Cooper shall exercise its commercially reasonable efforts to impart to AtriCure (whether by discussion, download of software or databases, preparation and delivery of hard-copy or other reasonable means) such information as may be
reasonably relevant or helpful to AtriCure to acquire the ability to manufacture the PRODUCTS. 
 (b) The parties intend that AtriCure will
during the MANUFACTURING TERM acquire the ability to itself manufacture the PRODUCTS. Cooper is delivering to AtriCure under the terms of this Agreement, information about suppliers of PRODUCTS and components thereof and, technical specifications,
drawings, marketing materials, sales information, service information and other materials necessary to manufacture the PRODUCTS (the “OPERATING INSTRUCTIONS”). To further facilitate AtriCure’s manufacture of the PRODUCTS,
during the MANUFACTURING TERM and for 6 months thereafter, Cooper shall, at no cost to AtriCure, provide to AtriCure know-how related to the manufacture of the PRODUCTS by making its personnel available to AtriCure personnel at the Cooper Facility
and for communications by telephone and email during business hours (9:00 a.m. to 5:00 p.m.) on Business Days. Without limiting the foregoing, Atricure’s personnel may, on not less than two (2) Business Days’ notice to Cooper, be
present at Cooper’s manufacturing facility at any time during Cooper’s business hours to monitor Cooper’s operation and performance of the MANUFACTURING SERVICES, including, but not limited to, videotaping Cooper’s performance of
the MANUFACTURING SERVICES. Subject to Cooper’s reasonable business requirements, during the MANUFACTURING 

  

 11 

 
TERM and the six month period immediately thereafter, Cooper shall make its personnel available to AtriCure at AtriCure’s facility at Cooper’s
fully loaded per diem cost for such employees, determined under generally accepted accounting principles, as consistently applied by Cooper, for any day or partial day that such employees are traveling to or from or are at AtriCure’s facility.
In the event that Cooper personnel travel to AtriCure to provide consulting services, AtriCure shall reimburse Cooper for all reasonable travel and other out-of-pocket expenses incurred by Cooper in connection with such travel using the same
standards used by Cooper for travel by such employees (i.e., first class or economy air travel, quality of hotels, etc.). 
 Section 13.
Representations, Warranties and Covenants of Cooper. 
 As a material inducement to AtriCure to enter into and perform its
obligations under this Agreement, Cooper represents and warrants to AtriCure as follows: 
 (a) Cooper is a corporation duly organized,
validly existing and in good standing under the laws of the State of Delaware. 
 (b) Cooper has all requisite corporate power and authority
to enter into this Agreement and to perform its obligations hereunder and to consummate the transactions contemplated hereby. Cooper’s execution, delivery and performance of this Agreement and its consummation of the transactions contemplated
hereby has been duly and validly authorized by all necessary corporate action. This Agreement has been duly and validly executed and delivered by Cooper and is the valid and binding obligation of Cooper enforceable against it in accordance with its
terms. 
 (c) The execution, delivery and performance of this Agreement by Cooper will not (x) violate any provision of the documents
pursuant to which Cooper was organized or which govern its existence, (y) violate, conflict with or result in the breach of or (with or without the giving of notice or the passage of time or both) entitle any party to terminate or declare a
default under any provision of any indenture, loan agreement or other agreement or instrument to which Cooper is a party or by which its properties or assets are bound, which would have an adverse affect on Cooper’s ability to perform its
duties and obligations under this Agreement, or (z) violate any Law, applicable to Cooper or its properties or assets, which would have an adverse affect on Cooper’s ability to perform its duties and obligations under this Agreement.

 (d) No litigation, arbitration, governmental or other proceeding or investigation is pending or, to Cooper’s knowledge, threatened
with respect to Cooper or its properties, assets or business that can reasonably be expected to interfere with Cooper’s execution, delivery and performance of this Agreement. No consent, authorization, approval, order, license, certificate or
permit of or from, or declaration or filing with, any Government Entity or tribunal, or any third Person (including shareholders), is required for Cooper to execute, deliver and perform this Agreement, except such that have been obtained, given or
made (as the case may be). 
  

 12 

 (e) There are no royalties, honoraria, fees or other payments payable by Cooper to any Person by reason
of the ownership, use, license, sale or disposition of the PRODUCT LINE. 
 (f) Cooper has good title to all PURCHASED ASSETS free and clear
of all ENCUMBRANCES, of any kind or character, except for PERMITTED ENCUMBRANCES. Except for inventory and supplies in transit in the ordinary course of business of the BUSINESS, all tangible personal property included in the PURCHASED ASSETS is
located at the Cooper Facility. 
 (g) Intentionally Deleted. 
 (h) Cooper has not received from any Person in the past five years any written notice, charge, complaint, claim or assertion and there is currently no
pending litigation alleging that the manufacture, sale or promotion of the PRODUCTS (including the use of the LICENSED MARK and CCS-200) interferes with, infringes upon, misappropriates or conflicts with the rights of any other Person, and no such
claim is impliedly threatened by an offer to license from another Person under a claim of use. 
 (i) Cooper has not sent to any Person in
the past five years any written notice, charge, complaint, claim or other assertion of any present, impending or threatened infringement by or misappropriation of, or other conflict with Cooper’s rights to the LICENSED MARK or CCS-200, by such
other Person or any acts of unfair competition by such other Person relating to the Products and Cooper is not currently prosecuting any such claim or suit. 
 (j) To the knowledge of Cooper, neither (i) the exercise by AtriCure of the License in and to the LICENSED MARK nor (ii) the promotion, manufacture and sale of the PRODUCTS, infringes upon the intellectual
property rights of any third party. 
 (k) After Closing, the MACHINERY AND EQUIPMENT will not be at any time used or operated by Cooper
other than for the performance of the MANUFACTURING SERVICES or upon the request of AtriCure. 
 (l) Neither Cooper nor any Affiliate of
Cooper nor any of the respective officers, directors, stockholders or employees of any of them has employed any broker or finder or incurred any liability for any brokerage fees, commissions or finders’ fees in connection with the transactions
contemplated hereby. 
 (m) The OPERATING INSTRUCTIONS contain all information necessary to enable a reasonable person to assemble and
install the Machinery and Equipment and engage in the manufacture of PRODUCTS identical to those PRODUCTS which Atricure has heretofore purchased from Cooper. 
 (n) All assets assigned to Atricure under Section 2(a)(ii) are, on the date hereof, in working order and good repair. 
  

 13 

 (o) The customer list, described in Section 2(a)(v), which was previously delivered to Atricure is
correct and complete in all material respects. 
 (p) Set forth on Schedule D is a true and correct list of all the Assigned Warranties.
Cooper has previously delivered to Atricure true and correct copies of all Assigned Warranties. 
 Cooper makes no other representations or
warranties with respect to the INTELLECTUAL PROPERTY RIGHTS, the PURCHASED ASSETS or the PRODUCT LINE, and, except for the representations and warranties in this Agreement, THE PURCHASED ASSETS ARE SOLD, CONVEYED, TRANSFERRED AND ASSIGNED TO
ATRICURE “AS IS.” THE WARRANTIES IN THIS AGREEMENT ARE IN LIEU OF, AND EXCLUDE, ALL OTHER WARRANTIES, EXPRESS OR IMPLIED, ORAL OR WRITTEN, INCLUDING WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. 
 Section 14. Representation and Warranties of AtriCure. 
 As a material inducement to Cooper to enter into and perform its obligations under this Agreement, AtriCure represents and warrants to Cooper as follows: 
 (a) AtriCure is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware. 
 (b) AtriCure has all requisite corporate power and authority to enter into this Agreement and to perform its obligations hereunder and to consummate the
transactions contemplated hereby. AtriCure’s execution, delivery and performance of this Agreement and its consummation of the transactions contemplated hereby has been duly and validly authorized by all necessary corporate action. This
Agreement has been duly and validly executed and delivered by AtriCure and is the valid and binding obligation of AtriCure enforceable against it in accordance with its terms. 
 (c) The execution, delivery and performance of this Agreement by AtriCure will not (x) violate any provision of the documents pursuant to which
AtriCure was organized or which govern its existence, (y) violate, conflict with or result in the breach of or (with or without the giving of notice or the passage of time or both) entitle any party to terminate or declare a default under any
provision of any indenture, loan agreement or other agreement or instrument to which AtriCure is a party or by which its properties or assets are bound, which would have an adverse affect on AtriCure’s ability to perform its duties and
obligations under this Agreement, or (z) violate any Law, applicable to AtriCure or its properties or assets, which would have an adverse affect on AtriCure’s ability to perform its duties and obligations under this Agreement. 

(d) No litigation, arbitration, governmental or other proceeding or investigation is pending or, to AtriCure’s knowledge, threatened with respect
to AtriCure or its properties, assets or business that can reasonably be expected to interfere with AtriCure’s execution, delivery and performance of this Agreement. No consent, authorization, approval, order, license, certificate or permit of
or from, or declaration or filing with, any Government Entity 

  

 14 

 
or tribunal, or any third Person (including shareholders), is required for AtriCure to execute, deliver and perform this Agreement, except such that have
been obtained, given or made (as the case may be). 
 (e) Neither AtriCure nor any affiliate of AtriCure nor any of the respective officers,
directors, stockholders or employees of any of them has employed any broker or finder or incurred any liability for any brokerage fees, commissions or finders’ fees in connection with the transactions contemplated hereby. 
 Section 15. Indemnification. 
 (a)
Indemnification Generally; Etc. 
 (i) Subject to the further terms of this Section 15, the COOPER INDEMNIFYING PERSONS
shall indemnify the ATRICURE INDEMNIFIED PERSONS for, and hold each of them harmless from and against, any and all ATRICURE LOSSES arising from or in connection with any of the following: 
 (A) the untruth, inaccuracy or breach of any representation or warranty of Cooper contained in Section 13; 
 (B) the breach of any agreement or covenant of Cooper contained in this Agreement (including the Schedules and the Exhibits attached hereto); and

 (C) the EXCLUDED LIABILITIES. 
 (ii) Subject to the further terms of this Section 15, the ATRICURE INDEMNIFYING PERSONS shall indemnify the COOPER INDEMNIFIED PERSONS for, and hold each of them harmless from and against, any and all COOPER LOSSES arising from
or in connection with any of the following: 
 (A) the untruth, inaccuracy or breach of any representation or warranty of AtriCure contained
in Section 14; 
 (B) the breach of any agreement or covenant of AtriCure contained in this Agreement (including the Schedules
and the Exhibits attached hereto); 
 (C) any and all ASSUMED LIABILITIES; and 
 (D) all LIABILITIES (contingent or otherwise and including LIABILITY for response costs, personal injury, property damage or natural resource damage),
which arise out of the manufacture, sale or promotion of the PRODUCTS by AtriCure after the Closing date that are not Excluded Liabilities. 
 (b) Assertion of Claims; Right of Setoff. 
 (i) No claim shall be brought under Section 15(a) hereof unless the
INDEMNIFIED PERSONS, or any of them, at any time prior to the applicable SURVIVAL 

  

 15 

 
DATE, give the INDEMNIFYING PERSONS (i) written notice of the existence of any such claim, specifying the nature and basis of such claim and the amount
thereof, to the extent known or (ii) written notice pursuant to Section 15(d) of any third party claim, the existence of which might give rise to such a claim. Upon the giving of such written notice as aforesaid, the INDEMNIFIED
PERSONS, or any of them, shall have the right thereafter to commence legal proceedings (including subsequent to the SURVIVAL DATE) for the enforcement of their rights under Section 15(a). 
 (c) Limitations on Indemnification. 
 (i) Indemnity Limitations. 
 (A) Except in the case of actual fraud, INDEMNIFIED PERSONS shall not have the right to be
indemnified for breaches of representations of INDEMNIFYING PERSONS in Section 13 and 14 of this Agreement unless and until the INDEMNIFIED PERSONS (or any of them) shall have incurred on a cumulative basis aggregate LOSSES in an amount
exceeding $50,000, in which event the right to be indemnified shall apply to the first dollar of such LOSSES. 
 (B) The sum of all LOSSES
pursuant to which indemnification is payable by the ATRICURE INDEMNIFYING PERSONS or by the COOPER INDEMNIFYING PERSONS for breaches of representations or warranties shall not exceed $2,000,000, except in the case of actual fraud. 
 (d) Notice and Defense of Third Party Claims. 
 The obligations and liabilities of an INDEMNIFYING PERSON with respect to LOSSES resulting from the assertion of liability by third parties (each, a “THIRD PARTY CLAIM”) shall be subject to the following terms and
conditions: 
 (i) An INDEMNIFIED PERSON shall promptly give written notice to the INDEMNIFYING PERSONS of any THIRD PARTY CLAIM which a
reasonable Person would likely conclude would give rise to any LOSSES of the INDEMNIFIED PERSONS which would be indemnifiable hereunder by the INDEMNIFYING PERSONS, stating the nature and basis of such THIRD PARTY CLAIM, and the amount thereof to
the extent known; provided, however, that no delay on the part of the INDEMNIFIED PERSONS in notifying any INDEMNIFYING PERSONS shall relieve the INDEMNIFYING PERSONS from any liability or obligation hereunder unless (and then solely
to the extent) the INDEMNIFYING PERSON is prejudiced by the delay. Such notice shall be accompanied by copies of all relevant documentation with respect to such THIRD PARTY CLAIM, including any summons, complaint or other pleading which may have
been served, any written demand or any other related document or instrument. 
 (ii) If the Indemnifying Persons shall acknowledge in a
writing delivered to the Indemnified Persons that the Indemnifying Persons shall be obligated under the terms of their indemnification obligations hereunder in connection with such Third Party Claim (i.e., that they shall be liable for any Losses,
arising out of such Third Party Claim), then the Indemnifying Persons shall have the right to assume the defense of any Third Party Claim at 

  

 16 

 
their own expense and by their own counsel, which counsel shall be reasonably satisfactory to the Indemnified Persons; provided, however, that
the Indemnifying Persons shall not have the right to assume the defense of any Third Party Claim, notwithstanding the giving of such written acknowledgment, if (i) the Indemnified Persons shall have been advised by counsel that there are one or
more legal or equitable defenses available to them which are different from or in addition to those available to the Indemnifying Persons, or, in the reasonable opinion of the Indemnified Persons, counsel for the Indemnifying Persons could not
adequately represent the interests of the Indemnified Persons because such interests could be in conflict with those of the Indemnifying Persons, (ii) such action or proceeding involves, or could have a material effect on, any material matter
beyond the scope of the indemnification obligation of the Indemnifying Persons or (iii) the Indemnifying Persons shall not have assumed the defense of the Third Party Claim in a timely fashion. 
 (iii) If the Indemnifying Persons shall assume the defense of a Third Party Claim (under circumstances in which the proviso to
Section 15(d)(ii) is not applicable), the Indemnifying Persons shall not be responsible for any legal or other defense costs subsequently incurred by the Indemnified Persons in connection with the defense thereof and the Indemnifying
Persons shall nevertheless be entitled to participate in such defense with their own counsel and at their own expense. If the Indemnifying Persons do not exercise their right to assume the defense of a Third Party Claim by giving the written
acknowledgement referred to in Section 15(d)(ii), or are otherwise restricted from so assuming by the proviso to Section 15(d)(ii), the Indemnified Persons may defend the Third Party claim and seek indemnity from the
Indemnifying Persons for Litigation Expenses incurred in connection with such defense. 
 (iv) If the Indemnifying Persons exercise their
right to assume the defense of a Third Party Claim, they shall not make any settlement of any such claim without the written consent of the Indemnified Persons, which consent shall not be unreasonably withheld; provided, however, that in the event
the Indemnifying Persons (A) submit to the Indemnified Persons a settlement agreement which provides for a settlement of the Third Party Claim by the payment of money only (the amount thereof being the “Settlement Amount”) and for an
unconditional release of the Indemnified Persons from all matters relating to such Third Party Claim by all claimants, (B) demonstrate, to the reasonable satisfaction of the Indemnified Persons, that all claimants are prepared to promptly
execute and deliver such settlement agreement and (C) demonstrate, to the reasonable satisfaction of the Indemnified Persons, the ability of the Indemnifying Persons to pay the Settlement Amount as provided in the settlement agreement and
(D) the Indemnified Persons shall not consent to such settlement within twenty (20) days after receipt of written notice thereof, any Losses incurred by the Indemnified Persons after such twentieth day which are in excess of the Settlement
Amount shall be at the sole expense of the Indemnified Persons. 
 (e) Survival of Representation and Warranties. 
 (i) The representations and warranties of Cooper and AtriCure contained in this Agreement shall survive the Closing Date and shall terminate on the second
anniversary of the Closing Date. 
  

 17 

 (ii) For convenience of reference, the date upon which any representation or warranty contained herein
shall terminate, if any, is referred to herein as the “SURVIVAL DATE”. 
 (f) Exclusive Remedy. 
 Except in the case of actual fraud, and except for any equitable relief which may be sought in connection with the NON-COMPETITION AGREEMENT and
Section 17 hereof, the rights and obligations provided for in this Section 15 shall be the sole and exclusive remedies of the Indemnified Persons with respect to any matter in any way relating to this Agreement or otherwise
relating to the transactions contemplated hereby or arising in connection herewith. 
 Section 16. Taking of Necessary Action; Further
Assurances. 
 Subject to the terms and conditions contained in this Agreement, the parties hereto shall take or cause to be taken all
such actions as may be necessary or appropriate in order to effectuate the SALE. In addition, Cooper shall cooperate, in a commercially reasonable manner in connection with Atricure’s efforts, subsequent to the Closing, to obtain licenses,
registrations and approvals necessary for Atricure to manufacture, market and/or sell the Products. Cooper’s cooperation shall include sending a letter to the FDA notifying the FDA of the Sale, the form and substance of such letter having been
agreed upon by the parties. 
 Section 17. Confidentiality. 
 (a) The relationship of the parties under this Agreement may involve the disclosure or delivery of their respective CONFIDENTIAL INFORMATION. The terms of this Agreement will govern the release and protection of any
such CONFIDENTIAL INFORMATION. In this Section, the party (including its Affiliates, directors, officers, employees and advisors) disclosing or making confidential information available is called the “DISCLOSING PARTY” and the party
(including its affiliates, directors, officers, employees and advisors) receiving or learning such information is called the “RECEIVING PARTY.” 
 (b) “CONFIDENTIAL INFORMATION” shall include any proprietary or nonpublic information identified by the DISCLOSING PARTY as such or which the RECEIVING PARTY knows, or has reason to know, is
confidential, proprietary or non-public relating to the DISCLOSING PARTY’S customers, products, plans designs, concepts, ideas, research, development, know-how, costs, prices, finances, marketing plans, business opportunities, personnel and any
other nonpublic technical or business information, including all specifications, plans, designs, drawings, concepts, ideas, research, development, know-how, analysis, studies and compilations ,or that of others which the DISCLOSING PARTY is
obligated to maintain in confidence, whether such information is disclosed or made available orally, visually or in writing (including any proprietary or non-public information, meeting the above description, which is acquired by Atricure from
Cooper under Section 2 of this Agreement). “CONFIDENTIAL INFORMATION” also shall include all notes, analyses, compilations, studies, interpretations or other documents prepared by the RECEIVING PARTY or its REPRESENTATIVES
which contain, reflect or are based upon, 

  

 18 

 
in whole or in part, the confidential, proprietary or nonpublic information of the DISCLOSING PARTY. CONFIDENTIAL INFORMATION does not, however, include
information that: (1) is now, or subsequently becomes generally available to the public through no fault or breach on the part of the RECEIVING PARTY; (2) the RECEIVING PARTY can demonstrate to have had rightfully in its possession without
an obligation of confidentiality prior to disclosure to the RECEIVING PARTY hereunder; (3) is independently developed by the RECEIVING PARTY without the use of any CONFIDENTIAL INFORMATION and without breach of this Agreement, as evidenced by
written documentation; (4) the RECEIVING PARTY rightfully obtains from a third party who has the right to transfer or disclose it and who provides it without a confidentiality obligation; or (5) is available to the RECEIVING PARTY by
lawful analysis of commercially available products; provided, however, that Section 17(b)(2) and (3) shall not apply to CONFIDENTIAL INFORMATION, if any, acquired by Atricure under Section 2. 
 (c) The RECEIVING PARTY: (a) acknowledges the proprietary and nonpublic nature of CONFIDENTIAL INFORMATION and will hold the same in confidence;
(b) will take all reasonable precautions to prevent any unauthorized use, disclosure, publication, or dissemination of CONFIDENTIAL INFORMATION; (c) will not copy, disclose, publish, or disseminate CONFIDENTIAL INFORMATION to anyone other
than those of its REPRESENTATIVES who need to know such information to further relationships of the parties under this Agreement, and (d) will not use CONFIDENTIAL INFORMATION for its own or any third Person’s benefit, and will only use it
to further the relationships of the parties under this Agreement. CONFIDENTIAL INFORMATION may be disclosed by the RECEIVING PARTY if required by Law, including Federal Securities Laws, or by a securities exchange or agency to which the RECEIVING
PARTY is subject. If the RECEIVING PARTY believes that it may be required by Law, or receives notice of an order by any judicial or other governmental entity that it is required, to disclose CONFIDENTIAL INFORMATION, it will promptly give the
DISCLOSING PARTY notice of such requirement to enable it to contest such requirement or order. Cooper acknowledges that Atricure will file this Agreement with the Securities and Exchange Commission as an exhibit to a Form 8-K. 
 (d) Except as otherwise provided in this Agreement, all information is provided by the Disclosing Party “AS IS” and without any warranties
regarding its completeness, performance, accuracy or non-infringement of third party rights. 
 (e) The parties hereby acknowledge that
unauthorized disclosure, or use of CONFIDENTIAL INFORMATION would cause irreparable harm and significant injury to the DISCLOSING PARTY which would be difficult to ascertain and that the DISCLOSING PARTY will have the right to seek and obtain
immediate injunctive relief to enforce obligations under this Agreement without any requirement to post a bond or other security, in addition to and not in lieu of any other rights and remedies it may have. 
 (f) During the MANUFACTURING TERM and for one year thereafter, the RECEIVING PARTY will return to the DISCLOSING PARTY promptly upon request, all
CONFIDENTIAL INFORMATION or derivatives thereof in any form or format, whether supplied or made available by the DISCLOSING PARTY or derived by the RECEIVING PARTY from CONFIDENTIAL INFORMATION. 
  

 19 

 Section 18. Complaints and Recalls. 
 (a) Each party hereto shall maintain complete and accurate records, in accordance with the requirements of applicable Law, of all PRODUCTS manufactured or
sold by it (each such product being hereinafter referred to as a “COVERED PRODUCT”). If either party receives a complaint, oral or written, regarding any COVERED PRODUCT, it will notify the other party, in writing and in reasonable
detail within the appropriate timeframe designated by applicable legal requirements, and the parties shall cooperate in good faith with each other with respect to such matter. 
 (b) If AtriCure desires to undertake a recall of any COVERED PRODUCT, it shall promptly notify Cooper. Cooper shall cooperate in good faith with AtriCure
as to the initiation and conduct of any recall of any COVERED PRODUCT, including communications with any purchasers or users thereof and with applicable regulatory authorities. 
 Section 19. Notices. 
 All notices, amendments, waivers, or other communications pursuant
to this agreement shall be in writing and shall be deemed to be sufficient if delivered personally, telecopied, sent by e-mail, sent by nationally-recognized, overnight courier or mailed by registered or certified mail (return receipt requested),
postage prepaid, to the parties at the following addresses (or at such other address for a party as shall be specified by like notice): 
  

	 	(a)	if to Cooper, to: 

 CooperSurgical, Inc. 
 95 Corporate Drive 
 Trumbull, Connecticut
06611 
 Attention: Nicholas Pichotta, CEO 
 Telephone: 203-601-5200 
 Facsimile: 203-601-1008 
 E-mail: jennifer.kropitis@coopersurgical.com 
                     and 
 nicholas.pichotta@coopersurgical.com 
 with copies to: 
 Carter Ledyard & Milburn LLP 
 2
Wall Street 
 New York, New York 10005-2072 
 Attention: David I. Karabell, Esq. 
 Telephone: 212-732-3200 
 Facsimile: 212-732-3232 
 E-mail:
karabell@clm.com 
  

 20 

	 	(b)	if to AtriCure, to: 

 AtriCure, Inc. 
 6033 Schumacher Park Drive 
 West Chester,
OH 45069 
 Attention: David J. Drachman, President 
 Telephone: 513-755-4100 
 Facsimile: 513-755-4108 
 E-mail: ddrachman@atricure.com 
 with a copies to: 
 Epstein Becker & Green, P.C. 
 250 Park Avenue 
 New York, New York 10177

 Attention: Theodore Polin, Esq. 
 Telephone: 212-351-4522 
 Facsimile: 212-878-8616 
 E-mail: tpolin@ebglaw.com 
 All such notices and other communications shall be deemed to have been
delivered and received (i) in the case of personal delivery or delivery by telecopy or e-mail, on the date of such delivery if delivered during business hours on a Business Day or, if not delivered during business hours on a Business Day, the
first Business Day thereafter, (ii) in the case of delivery by nationally-recognized, overnight courier, on the Business Day following dispatch, and (iii) in the case of mailing, on the third Business Day following such mailing.

 Section 20. Governing Law; Waiver of Jury Trial. 
 (a) All questions concerning the construction, interpretation and validity of this agreement shall be governed by and construed and enforced in accordance with the domestic Laws of the State of New York, without
giving effect to any choice or conflict of law provision or rule (whether in the State of New York or any other jurisdiction) that would cause the application of the Laws of the jurisdiction other than the State of New York. In furtherance of the
foregoing, the internal Laws of the State of New York will control the interpretation and construction of this Agreement, even if under such jurisdiction’s choice of law or conflict of law analysis, the substantive Laws of some other
jurisdiction would ordinarily or necessarily apply. 
 (b) BECAUSE DISPUTES ARISING IN CONNECTION WITH COMPLEX FINANCIAL TRANSACTIONS ARE
MOST QUICKLY AND ECONOMICALLY RESOLVED BY AN EXPERIENCED AND EXPERT PERSON AND THE PARTIES WISH APPLICABLE LAWS TO APPLY (RATHER THAN ARBITRATION RULES), THE PARTIES DESIRE THAT THEIR DISPUTES BE RESOLVED BY A JUDGE APPLYING SUCH APPLICABLE LAWS.
THEREFORE, TO ACHIEVE THE BEST 

  

 21 

 
COMBINATION OF THE BENEFITS OF THE JUDICIAL SYSTEM, EACH PARTY HERETO IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, SUIT OR PROCEEDING BASED
UPON OR ARISING OUT OF THIS AGREEMENT OR ANY DEALINGS BETWEEN THE PARTIES HERETO RELATING TO THE SUBJECT MATTER HEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT
RELATE TO THE SUBJECT MATTER OF THIS AGREEMENT, INCLUDING, CONTRACT CLAIMS, TORT CLAIMS, BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. EACH PARTY HERETO ACKNOWLEDGES THAT THIS WAIVER IS A MATERIAL INDUCEMENT TO ENTER INTO
THIS AGREEMENT. EACH PARTY HAS REVIEWED THIS WAIVER WITH ITS RESPECTIVE LEGAL COUNSEL, AND KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH SUCH LEGAL COUNSEL. IN THE EVENT OF LITIGATION, THIS AGREEMENT MAY BE FILED
AS A WRITTEN CONSENT TO A TRIAL BY THE COURT. 
 (c) EACH PARTY IRREVOCABLY AND UNCONDITIONALLY AGREES THAT PROCESS MAY BE SERVED UPON IT BY
CERTIFIED MAIL, RETURN RECEIPT REQUESTED OR REPUTABLE OVERNIGHT COURIER (SUCH AS FEDERAL EXPRESS), ADDRESSED AS MORE GENERALLY PROVIDED IN SECTION 19 HEREOF, AND CONSENTS TO THE EXERCISE OF JURISDICTION OVER IT AND ITS PROPERTIES BY STATE AND
FEDERAL COURTS OF NEW YORK LOCATED IN THE COUNTY OF NEW YORK WITH RESPECT TO ANY ACTION, SUIT OR PROCEEDING ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THE ENFORCEMENT OF ANY RIGHTS UNDER THIS
AGREEMENT. SUCH SERVICE OF PROCESS SHALL BE DEEMED COMPLETE WHEN THE NOTICE CONTEMPLATED HEREBY IS DEEMED DELIVERED UNDER SECTION 19 HEREIN. 
 Section 21. Counterparts; Facsimile and Electronic Signatures. 
 This agreement may be executed in two or more
counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same instrument. Facsimile and electronic counterpart signatures to this agreement shall be acceptable and binding. 
 Section 22. Successors and Assigns. 
 The
terms and provisions of this agreement shall be binding upon and inure to the benefit of the parties and their respective successors and assigns. 
 Section 23. Amendment, Waiver; Breach. 
 (a) This agreement shall not be altered or otherwise amended except
pursuant to an instrument in writing signed by each party, except that any party may waive in writing any obligation owed to it by another party under this agreement. No waiver by any party of any 

  

 22 

 
default, misrepresentation, or breach of warranty or covenant hereunder, whether intentional or not, shall be deemed to extend to any prior or subsequent
default, misrepresentation, or breach of warranty or covenant hereunder or affect in any way any rights arising by virtue of any prior or subsequent such occurrence. 
 Section 24. Construction. 
 Unless the context clearly requires otherwise, this agreement
shall be construed in accordance with the following rules: 
 (a) The Section numbers and headings preceding text have been inserted for
convenient reference only and shall not affect the meaning, construction or effect of this Agreement. 
 (b) References to Sections, Exhibits
and Schedules are references to Sections of this Agreement and Exhibits and Schedules attached to this Agreement, respectively, which attached Exhibits and Schedules are hereby incorporated by reference and made a part of this Agreement. 

(c) Words in the singular include the plural and words in the plural include the singular. 
 (d) The use in this Agreement of the term “including” means “including without limitation.” The words “herein,”
“hereof,” “hereunder,” “hereby,” “hereto” and other words of similar import refer to this Agreement as a whole, as it may from time to time be amended. 
 [SIGNATURE PAGE FOLLOWS] 
  

 23 

 IN WITNESS WHEREOF, each of the undersigned has caused this Agreement to be executed on its behalf as of
the date first above written. 
  

			
	COOPERSURGICAL, INC.
		
	By:	 	 /s/ Nicholas J. Pichotta

	Name:	 	Nicholas J. Pichotta
	Title:	 	President and Chief Executive Officer
	
	ATRICURE, INC.
		
	By:	 	 /s/ David J. Drachman

	Name:	 	David J. Drachman
	Title:	 	President and Chief Executive Officer

  

 24 

 Attachments: 
  

			
	Annex 1 -	  	Definition of Terms
		
	Schedule A -	  	Products
		
	Schedule B -	  	Machinery and Equipment
		
	Schedule C -	  	Inventory
		
	Schedule D -	  	Assigned Warranties
		
	Schedule E -	  	Transferable Approvals
		
	Schedule F -	  	Not Included
		
	Schedule G -	  	Console Delivery
		
	Schedule H -	  	Probe Delivery
		
	Exhibit 1 -	  	Promissory Note
		
	Exhibit 2 -	  	Non-Competition Agreement

  

 25 

 ANNEX I 
 CERTAIN DEFINITIONS 
 “Affiliate” means, any other Person that, directly or
indirectly through one or more intermediaries, Controls, or is Controlled by, or is under common Control with, such Person. 
 “Assigned Warranty” has the meaning assigned thereto in Section 2(a)(vii). 
 “AtriCure Indemnified
Persons” means AtriCure, its successors and assigns, and the respective officers and directors of each of the foregoing. 
 “AtriCure Indemnifying Persons” means AtriCure and its successors and assigns. 
 “AtriCure
Losses” means any and all Losses sustained, suffered or incurred by any of the AtriCure Indemnified Persons arising from or in connection with any matter which is the subject of indemnification under Section 15(a)(i).

 “Business Day” means any day that is not a Saturday, Sunday or a day on which banking institutions in New York, New York
are not required to be open. 
 “Closing” means the closing of the sale of the PURCHASED ASSETS to AtriCure, and the
transactions contemplated by this Agreement, which shall take place at the offices of Carter Ledyard & Milburn LLP, 2 Wall Street, New York, New York, on the date hereof (the “Closing Date”). 
 “Control” means, with respect to any Person, the possession, directly or indirectly, of the power to direct or cause the direction of
the management or policies of a Person, whether through the ownership of voting securities, by contract or otherwise. 
 “Cooper
Indemnified Persons” means Cooper and its successors and assigns and the respective officers and directors of each of the foregoing. 
 “Cooper Indemnifying Persons” means Cooper and its successors and assigns. 
 “Cooper Losses”
means any and all Losses sustained, suffered or incurred by any Cooper Indemnified Person arising from or in connection with any matter which is the subject of indemnification under Section 15(a)(ii). 
 “Encumbrances” means any security interests, mortgages, deeds of trust, liens, pledges, charges, claims, easements, reservations,
restrictions, clouds, equities, rights of way, options, rights of first refusal, grants of power to confess judgment, conditional sales and title retention agreements (including any lease in the nature thereof) and all other encumbrances, whether or
not relating to the extension of credit or the borrowing of money. 

 “Enhanced Product Line” means collectively, (a) the Products and (b) any other
nitrous oxide-based cryogenic consoles and other hardware and related probes intended for use solely in cardiac surgical procedures. 
 “Governmental Entity” means any Federal, state, local, foreign, political subdivision, court, administrative agency, commission or department or other governmental authority or instrumentality. 
 “Indemnified Persons” means and includes the Cooper Indemnified Persons and/or the AtriCure Indemnified Persons, as the case may be.

 “Indemnifying Persons” means and includes the Cooper Indemnifying Persons and/or the AtriCure Indemnifying Persons, as
the case may be. 
 “Law” means any law, statute, treaty, rule, directive or regulation or Order of any Governmental Entity,
including the FDA’s then current Good Manufacturing Practices; 
 “Liability” means any liability or obligation,
whether known or unknown, asserted or unasserted, absolute or contingent, accrued or unaccrued, liquidated or unliquidated and whether due or to become due, regardless of when asserted. 
 “Litigation Expense” means any expenses incurred in connection with investigating, defending or asserting any claim, legal or
administrative action, suit or Proceeding incident to any matter indemnified against under Section 15 including court filing fees, court costs, arbitration fees or costs, witness fees and fees and disbursements of legal counsel,
investigators, expert witnesses, accountants and other professionals. 
 “Losses” means any and all losses, claims,
shortages, damages, Liabilities, expenses (including Litigation Expenses), assessments, Tax deficiencies, Taxes (including interest or penalties thereon) arising from or in connection with any such matter that is the subject of indemnification under
Section 15, net of any amounts recovered (net of deductibles) by the Indemnified Persons under insurance policies with respect to such Losses. 
 “Manufacturing Term” means the period beginning on the date hereof and ending on the Manufacturing Termination Date. 
 “Manufacturing Termination Date” has the meaning given it in Section 10(c). 
 “Orders” means judgments, writs, decrees, compliance agreements, injunctions or orders of any Governmental Entity or arbitrator and guidelines issued by any Governmental Entity administering any environmental, health and
safety laws. 
 “Permits” means all permits, licenses, authorizations, registrations, franchises, approvals, certificates,
variances and similar rights obtained, or required to be obtained, from Governmental Entities. 

 “Permitted Encumbrances” means (i) Encumbrances for taxes not yet due and payable
or being contested in good faith by appropriate proceedings and for which there are adequate reserves on the books; (ii) workers or unemployment compensation liens arising in the ordinary course of business; and (iii) mechanic’s,
materialman’s, supplier’s, vendor’s or similar liens arising in the ordinary course of business securing amounts that are not delinquent. 
 “Person” shall be construed broadly and shall include an individual, a partnership, a corporation, a limited liability company, an association, a joint stock company, a trust, a joint venture, an
unincorporated organization or another entity including a Governmental Entity (or any department, agency or political subdivision thereof). 
 “Tax” or “Taxes” means, with respect to any Person, (i) all income taxes (including any tax on or based upon net income, gross income, income as specially defined, earnings, profits or selected items
of income, earnings or profits) and all gross receipts, sales, use, ad valorem, transfer, franchise, license, withholding, payroll, employment, excise, environmental (including taxes under Code Section 59A), social security, severance, stamp,
occupation, premium, property or windfall profits taxes, alternative or add-on minimum taxes, customs duties and other taxes, fees, assessments or charges of any kind whatsoever, together with all interest and penalties, additions to tax and other
additional amounts imposed by any taxing authority (domestic or foreign) on such Person (if any) and (ii) any liability for the payment of any amount of the type described in clause (i) above as a result of (A) being a
“transferee” (within the meaning of Section 6901 of the Code or any other applicable Law) of another Person, (B) being a member of an affiliated, combined or consolidated group or (C) a contractual arrangement or
otherwise. 

 Schedule A 
 PRODUCTS 
  

	 	•	CCS-200 Cardiovascular Cryosurgery Unit 

  

	 	•	CCS-200 Cardiovascular Probes: 

  

	 	•	CCS-200 Maze Linear Probe 

  

	 	•	CCS-200 15mm Diameter Flat Face, Curved Probe 

  

	 	•	CCS-200 25mm Diameter Cone Tip 

  

	 	•	CCS-200 3mm Diameter Flat Tip 

  

	 	•	CCS-200 6.4mm “J” Probe 

  

	 	•	CCS-200 5mm Angled Curved Tip 

  

	 	•	CCS-200 5mm Diameter Flat Face, Curved Probe 

  

	 	•	CCS-200 4mm Diameter Straight Trocar Probe 

  

	 	•	CCS-200 5mm Diameter Straight Trocar Probe 

  

	 	•	CCS-200 5mm Diameter Offset Flat Tip 

  

	 	•	CCS-200 15mm Diameter Offset Flat Tip 

  

	 	•	CCS-200 5mm x 20mm Tip 

  

	 	•	CCS-200 9mm Diameter x 30mm Long Freeze Tip 

  

	 	•	CCS-200 10mm Diameter Offset Cone Tip 

  

	 	•	CCS-200 10mm Diameter Offset Flat Tip 

  

	•	 	 CCS-200 25mm Diameter Flat Face 

 Schedule B 
 Machinery and Equipment 
  

			
	 Item
	  	 Description

	 1
	  	Vise (Soft Jaw)
	 2
	  	Special Tool “A”
	 3
	  	Torque Wrench Fixture #40767 (used with spanner socket below)
	 4
	  	Spanner Socket w/ 2 pins
	 5
	  	Fixture # 40953
	 6
	  	Hot Plates (3)
	 7
	  	Stainless Steel Beakers (2)
	 8
	  	Stainless Steel Pan
	 9
	  	Cushioned Jaw Pliers
	 10
	  	“Modified” Pliers
	 11
	  	Bender with Shaping Wheel
	 12
	  	Solderite, non asbestos welding plates
	 13
	  	Oxy-Acetylene Micro Torch
	 14
	  	Ultrasonic Tank #3 Oakite
	 15
	  	Ultrasonic Tank # 2 Continuous Flow
	 16
	  	Buffer with ScotchBrite Wheel (Red) & Rouge Wheel (green)
	 17
	  	Sheet Metal Welding Fixture
	 18
	  	Vent Hood Fixture w/ “Electroclean” Tank, Water Spray-Off Tank, Acid Tank, Gold Plate Tank
	 19
	  	Heat Gun
	 20
	  	Calipers
	 21
	  	Fixture #40170 (to check flow - reference only)
	 22
	  	Meter DVM
	 23
	  	Stencil Machine (Mark 300)
	 24
	  	Double Door Oven (#4) (located in Cleanroom)
	 25
	  	Powder Bin
	 26
	  	Filter Installation Press
	 27
	  	Wire Welder - ID ME00016
	 28
	  	Induction Brazer
	 29
	  	Pressure Test Chamber # 503
	 30
	  	Tig Welder
	 31
	  	Flow Gauge # 326
	 32
	  	Fixture # 41010 (Cardio)
	 33
	  	Fixture # 40782
	 34
	  	Line Crimping Arbor Press (w/ Fixture # 30934-1 & 30934-2)

 Schedule C 
 Inventory 
 Cooper is to deliver to AtriCure within two weeks of Closing the following finished goods
inventory: 
 4 Consoles and the following Probes: 
  

					
	 	  	 	  	 Number of Probes
 to Be Delivered

	 P3004
	  	25mm Flat Face probe	  	6
			
	 P3005
	  	5 mm Flat Face, Curved Probe	  	1
			
	 P3010
	  	6.4mm “J” Probe	  	2
			
	 P3011
	  	Maze Linear Probe	  	2
			
	 P3014
	  	5mm x 20mm Angled Probe	  	12
			
	 P3015
	  	15mm Curved Probe	  	8
			
	 P3016
	  	15mm Offset Flat Tip	  	4

 The balance of Schedule C follows: 

					
	 Part#
	  	 Description
	  	Qty.
	 3050
	  	CCS-200 CONSOLE	  	0
	 3031
	  	22GA THERM RED	  	1
	 3032
	  	22GA THERM YELLOW	  	1
	 3039
	  	22GA THERM NEEDLE RED	  	20
	 3041
	  	22 Ga TC Yellow	  	20
	 10026
	  	6/32 HEX NUT CAD PLAT-	  	180
	 10027
	  	10/32 X 3/8 BINDING HA	  	40
	 10032
	  	HEX NUT SS 10-32 -	  	160
	 10241
	  	5/16 INTERNAL TOOTH L-	  	80
	 10260
	  	MS FLHD SS 4-40 X 3/8	  	80
	 10260
	  	MS FLHD SS 4-40 X 3/8-	  	80
	 10313
	  	9 VOLT,ALKALINE BATTE-	  	80
	 10424
	  	#10 SS SPLIT LOCK WAS-	  	160
	 10425
	  	1/2-13 HEX JAM NUT SS-	  	40
	 10536
	  	STOP NUT SELF LOCKING	  	260
	 10665
	  	WASHER, FLAT, CRS. A	  	40
	 10914
	  	LOCK WASHER INTERNAL C	  	40
	 10924
	  	O RING NEOPRENE 70 DUA	  	20
	 10924
	  	O RING NEOPRENE 70 DUA	  	40
	 10948
	  	WASHER .875 X .505 NICKLE	  	581
	 10978
	  	HAND TIGHT NUT #613-2-	  	40
	 10992
	  	HEX CAP SCREW 1/2-13 -	  	40
	 20021
	  	TUBG-COPPER 1/4 X .03	  	379
	 20022
	  	TUBG-COPPER 1/8 X 1/1-	  	146
	 20305
	  	O-RING VITON PARKER S-	  	40
	 20308
	  	O-RING PARKER SIZE 2-	  	40
	 20310
	  	FILTER 20 MICRONS .25-	  	20
	 20320
	  	O-RING POLYURETHANE C	  	40
	 20332
	  	CONNECTOR-FEMALE BULKA	  	20
	 20337
	  	ELBOW MALE 1/8 TUBE T-	  	120
	 20339
	  	ELBOW FEMALE 4-4DTX-SA	  	40
	 20340
	  	Pressure Gauge 1000PSB	  	40
	 20340
	  	Pressure Gauge 1000PSB	  	40
	 20340
	  	Pressure Gauge 1000PSB	  	20
	 20349
	  	REDUCER 1/4 X 1/8 NPT-	  	20
	 20349
	  	REDUCER 1/4 X 1/8 NPT-	  	40
	 20403
	  	SCREW CROSS RECESS STA	  	40
	 20412
	  	SPLIT LOCKWASHER 1/2”A	  	40
	 20434
	  	UNION FITTING PARKER -	  	40
	 20439
	  	O-RING BUNA N #2-016-C	  	80
	 20440
	  	O RING BUNA N #2-012-N674	  	40
	 20440
	  	O RING BUNA N #2-012--	  	40
	 20441
	  	NUT HEX 11/16-24 X 3/16	  	40
	 20445
	  	LOCK O SEAL WASHER #8-	  	40

					
	 20503
	  	DECORATIVE TRIM 1/2 X-	  	213
	 20507
	  	MALE BRANCH TEE #2SBI2B	  	8
	 20507
	  	MALE BRANCH TEE #2SBI-	  	40
	 20507
	  	MALE BRANCH TEE #2SBI-	  	20
	 20510
	  	GAUGE DECAL-VENDOR TOB	  	20
	 20598
	  	female Elbow	  	168
	 21094
	  	LOCKNUT 1/4” STEEL CA-	  	20
	 21108
	  	WASHER FLAT SS 1 1/4	  	40
	 21210
	  	SCREW SET 8-32 X 3/16-	  	40
	 21389
	  	SCREW 6-32 X 1/4 BUTT-	  	40
	 21461
	  	SING CONDUC WIRE 22 A-	  	40
	 21461
	  	SING CONDUC WIRE 22 A-	  	40
	 21462
	  	WIRE AWG 22 STRND OFH-	  	120
	 21702
	  	TBG VINYL PVC CLEAR 3B	  	400
	 21710
	  	SCINTERED FILTER 65 MICRO	  	20
	 21711
	  	FML PIPE CROSS 1/4 BRASS	  	66
	 21719
	  	GAS PURIFR SHELL(HOUS-	  	20
	 21720
	  	REPLCABLE(FILTER)CARTB	  	20
	 21836
	  	NIPPLE 3/32 THICK CHRC	  	40
	 21837
	  	TIP REPLACEMENT NIPPL-	  	40
	 21846
	  	FINE METERING VALVE NU	  	140
	 21847
	  	VERNIER HANDL BLACK NYLON	  	148
	 21851
	  	BULKHEAD ADAPTER EASTMAN	  	20
	 21854
	  	ML CONN 1/4 MNPT X 1/4 OD	  	91
	 21866
	  	SHRINK TUBE 3/64 BLAC	  	8.5
	 21910
	  	CASTER W/BRAKES 3 INCC	  	80
	 21912
	  	RECTNGLR INSERT 1 1/2	  	80
	 21922
	  	BALL VALVE 3 WAY WHITA	  	40
	 22027
	  	BALL VALVE WHITEY #B-43F2	  	101
	 22028
	  	MALE ELBOW #4-CBI2-B	  	122
	 22029
	  	MALE RUN TEE BRASS PARKER	  	114
	 22036
	  	ELBOW FEMALE 1/4 FNPT X	  	212
	 22037
	  	CHECK VALVE NUPRO B-4C2-	  	104
	 22038
	  	END CAP FOR 2 1/8 COPPER	  	40
	 22039
	  	FITTING ADAPTER	  	133
	 22040
	  	TBG COPPER 2 ID X 1/16	  	15
	 22041
	  	BRONZE WOOL FINE MCMASTER	  	2
	 22042
	  	ELBOW MALE 1/4 MNPT X 1/4	  	257
	 22043
	  	BALL VALVE 3 WAY	  	104
	 22046
	  	WIRE 24 AWG YELLOW	  	375
	 22047
	  	WIRE 24 AWG BLACK	  	561
	 22048
	  	WIRE 24 AWG RED	  	761
	 22049
	  	WIRE 24 AWG RED/WHITE	  	331
	 22050
	  	WIRE 24 AWG YELLOW/WHITE	  	382
	 22051
	  	WIRE 24 AWG ORANGE	  	525
	 22052
	  	WIRE 24 AWG ORANGE/WHITE	  	819
	 22053
	  	WIRE 24 AWG GREY/WHITE	  	841
	 22054
	  	WIRE 24 AWG GREEN/WHITE	  	282

					
	 22055
	  	WIRE 24 AWG BLACK/WHITE	  	1033
	 22056
	  	WIRE 24 AWG BROWN/WHITE	  	431
	 22057
	  	NEEDLE 19GA HYPODERMIC	  	247
	 22058
	  	SCRW 8-32 X 1/4 LONG BUTT	  	1484
	 22059
	  	VALVE KNOB,RED WHITEY BZ-	  	93
	 22062
	  	COUPLING 1/8 FNPT X 1/8	  	40
	 22063
	  	FML BRANCH TEE 1/8 FNPT X	  	157
	 22064
	  	HOSE CLAMP (MUFFLER)	  	124
	 22065
	  	PANEL ADAPTER CLIP PLATED	  	40
	 22066
	  	RESISTOR 510 OHM 1/4 WATT	  	329
	 22067
	  	LED MTG CLIP T-1 3/4 SOLI	  	858
	 22068
	  	LED,YELLOW SOLICO	  	64
	 22069
	  	LED,RED SOLICO #SOLR-322/	  	66
	 22070
	  	MINI PANEL JACK YLW #EI 1	  	40
	 22071
	  	MIN PANEL JACK RED #EI 17	  	119
	 22072
	  	SWITCH TOGGLE ON/OFF	  	20
	 22073
	  	SWITCH TOGGLE ON/NONE/ON	  	82
	 22074
	  	TIMER WESTBEND CATALOG #	  	130
	 22075
	  	STREET TEE 1/4 PARKER	  	76
	 22076
	  	MALE BRANCH TEE 1/8 MNPT	  	40
	 22077
	  	37* SWVL TO 1/4 MNPT SLVR	  	69
	 22078
	  	SCREW 10-32 X 3/8 BUTTON	  	448
	 22087
	  	BATTERY HOLDER DUAL 9V	  	40
	 22137
	  	CONNECTOR WIRE VINYLU	  	80
	 22608
	  	NYLON BUSHING	  	231
	 22648
	  	DELRIN ROD 1\4 INCH	  	7
	 23504
	  	1-64X1/4 FIL. HD. SCREW	  	840
	 30407
	  	SPRING SOCKET FABRICAC	  	40
	 30413
	  	ACTUATOR PLUG MFG P/PC	  	40
	 30684
	  	SPRING HOUSING MFG P/B	  	40
	 30685
	  	SOCKET END MFG P/PRINF	  	40
	 30686
	  	SPRING GUIDE MFG P/PRA	  	40
	 30687
	  	RETAINING SCRW NATL DA	  	40
	 30688
	  	SOCKET PROBE MFG P/PRE	  	40
	 31442
	  	QUICK DISCONNECT MFG C	  	40
	 32149
	  	BELT ASSY-BLACK NYL #C	  	40
	 32910
	  	BARB CONNECTOR PLATED	  	20
	 33106
	  	NON-SLIP MAT -	  	20
	 33529
	  	MALE BRANCH T MODIFIED	  	32
	 33530
	  	GAUGE DECAL	  	40
	 33538
	  	CAUTION LABEL-CARRIER	  	410
	 33843
	  	IDENTIFICATION PLATE,C	  	20
	 33843
	  	IDENTIFICATION PLATE,C	  	20
	 34031
	  	DIGITAL TEMP METER CRF	  	60
	 34034
	  	SPACER A	  	240
	 34113
	  	METER MOUNTING BRACKET	  	114
	 34135
	  	PLEXIGLAS WINDOW/ADPT. CC	  	278
	 35372
	  	CCS-200 OPERATION MANUAL	  	32

					
	 35638
	  	WARRANTY CARD-GREEN -	  	20
	 35771
	  	FRIGATRONICS LABEL -	  	40
	 35970
	  	BATTERY CABLE FOR CCS200	  	60
	 52337
	  	MUFFLER ASSY	  	20
	 53130
	  	SHIPPING SYSTEM,CCS20-	  	20
	 10015-1
	  	WALDEN CONN.22-16 WIR-	  	40
	 10107-1
	  	NYLON TIE WRAPS T & BA	  	260
	 10379-2
	  	HEX NUT 5/16-18 -	  	80
	 20370-3
	  	PRESSURE HOSE SYNFLEXB	  	40
	 33104-202
	  	BOTTLE BRACKET PAINTEB	  	40
	 33105-202
	  	BOTTOM TRAY PAINTED B	  	20
	 33531-202
	  	BRKT HARNESS STAB-PNT	  	57
	 33532-202
	  	ENCLOSURE COVER PLATE PN	  	65
	 33535-202
	  	TIMER MOUNTING BRACKET FA	  	16
	 33536-202
	  	SHROUD-PAINTED	  	54
	 33539-202
	  	LEG DUAL CYL CART	  	74
	 52344-303
	  	CCS-200 ENCLOSURE SILK-	  	71
			
	 Part#
	  	 Description
	  	QTY.
	 3003
	  	3MM FLAT CARDIAC PROBE	  	13
	 3004
	  	25MM FLAT CERVIX PROBE	  	8
	 3005
	  	5MM CURVED PROBE	  	1
	 3007
	  	4MM TROCAR PROBE	  	4
	 3008
	  	5MM TROCAR*DISCONTINUED*	  	1
	 3009
	  	5MM OFFSET FLAT TIP	  	1
	 3010
	  	5mm J Probe	  	14
	 3011
	  	MAZE PROCEDURE LINEAR PRB	  	12
	 3012
	  	25MM CONE CARDIAC PROBE	  	0
	 3014
	  	5mm x 20mm Angled Probe	  	17
	 3015
	  	15MM CURVED PROBE	  	7
	 3016
	  	15MM OFFSET FLAT TIP	  	9
	 3017
	  	8-10MM/30MM CARDIAC PRB	  	4
	 3018
	  	10MM OFFSET FLAT TIP	  	1
	 10889
	  	SILICONE TUBING 1/2 OD X	  	0.42
	 10945
	  	HEX NUT 4-48 UNF 2B B-	  	40
	 20224
	  	LIGHTWEIGHT NATURAL	  	201.54
	 20302
	  	O-RING VITON 75 DUROM-	  	80
	 20446
	  	FILTER 50 MICRON .125A	  	40
	 20475
	  	CASE W/INSERT LRG BLACK	  	217
	 20485
	  	COMPRESSION SPRING LE-	  	40
	 20568
	  	WIRE 30GA SOLID COPPE-	  	40
	 20603
	  	HOSE BLACK NYLON 1/8 B	  	340
	 20784
	  	WIRE CPPR CONSTANTAN -	  	40
	 20811
	  	SHRINK TUBING WHITE S-	  	40
	 20896
	  	TBG N2 NYLON .187 OD -	  	320
	 21461
	  	SING CONDUC WIRE 22 A-	  	340

					
	 21462
	  	WIRE AWG 22 STRND OFH-	  	340
	 21885
	  	TBG SILIC WHITE .300 ID X	  	320
	 21885
	  	TBG SILIC WHITE .300 B	  	52
	 21885
	  	TBG SILIC WHITE .300 B	  	48
	 21903
	  	TBG SS T304 .109 OD XC	  	7.968
	 22022
	  	TBG SILIC 1/4 OD X 3/16	  	100
	 22938
	  	HEAT SHRINK TUBING .141ID	  	340
	 22938
	  	HEAT SHRINK TUBING .1-	  	340
	 30680
	  	INSULATOR PLUG MFG P/B	  	40
	 30682
	  	PAWL PLUG RELEASE FABF	  	40
	 30683
	  	CENTRAL TUBE INSUL MFG	  	40
	 30691
	  	PLUG VALVE NOSE MFG PA	  	40
	 30692
	  	PAWL NUT FABRICATE P/C	  	40
	 32267
	  	HEMOR TIP MPP 32267LR AS	  	37
	 33140
	  	SUPPORT COLLAR	  	48
	 33141
	  	EXHAUST LINE COLLAR	  	153
	 33142
	  	DELIVERY LINE COLLAR	  	106
	 33143
	  	CONNECTOR ADAPTER MFG PER	  	40
	 33144
	  	DELIVER TUBE 5MM TROCAR	  	15
	 33145
	  	DELIVERY TUBE 5MM PROBE	  	8
	 33146
	  	DELIVERY TUBE 15MM PROBE	  	39
	 33148
	  	INSULATOR TUBE 5MM	  	33
	 33149
	  	TUBE INSULATOR 15MM PROBE	  	81
	 33150
	  	ADAPTER SCREW BOILER	  	130
	 33151
	  	ADAPTER SUPPORT	  	173
	 33152
	  	PROBE SUPPORT	  	198
	 33153
	  	5MM PIERCE TIP	  	13
	 33154
	  	5MM BOILER TIP	  	18
	 33155
	  	15MM BOILER TIP	  	25
	 33159
	  	CONNECTOR PLUG MALE	  	173
	 33160
	  	CONN ADPTR EXHST PLUG	  	145
	 33161
	  	CENTRAL SHAFT	  	47
	 33162
	  	DEL LINE ADAPTER	  	276
	 33163
	  	CONNECTOR ADAPTER	  	265
	 33166
	  	SHAFT Y CONN.	  	220
	 33167
	  	EXTENSION Y CONN	  	545
	 33168
	  	RETAINING SPRING	  	60
	 33171
	  	SUPPORT TUBE	  	137
	 33416
	  	SILICONE TUBING	  	48
	 33426
	  	EXHAUST TUBE	  	8
	 33446
	  	DELIVERY TUBE	  	6
	 33447
	  	TUBE INSULATOR	  	16
	 33448
	  	EXHAUST TUBE	  	14
	 33449
	  	BODY	  	25
	 33450
	  	15 MM OFFSET FLAT TIP	  	31
	 33452
	  	10MM OFFSET CONE TIP	  	16
	 33453
	  	10MM OFFSET FLAT TIP	  	23
	 33454
	  	INSULATING CAP	  	27

					
	 33637
	  	BOILER TIP 3MM PEDIATRIC	  	86
	 33642
	  	BOILER ADAPTER SCREW FAB	  	44
	 33643
	  	DELIVERY TUBE	  	79
	 33649
	  	DELIVERY TUBE	  	45
	 33671
	  	3014 Cardiac Boiler Tip	  	18
	 33672
	  	DELIVERY TUBE-3014	  	180
	 33673
	  	Cardiac Boiler Tube	  	19
	 35347
	  	DELIVERY TUBE	  	18
	 35420
	  	DELIVERY TUBE	  	4
	 35422
	  	5mm x 1.00 BOILER TIP	  	118
	 35638
	  	WARRANTY CARD-GREEN -	  	40
	 52068
	  	FILTER ASSY	  	34
	 52068
	  	FILTER ASSY -	  	40
	 52071
	  	PROBE SUPPORT ASSY WELD	  	28
	 52072
	  	FREEZE TIP & EXHAUST HOSE	  	10
	 52080
	  	FREZE TIP & EXHAUST ASSY	  	1
	 52081
	  	FREEZE TIP & EXHAUST ASSY	  	9
	 52082
	  	FREEZE TIP & EXHAUST ASSY	  	2
	 52083
	  	DEL & EXHAUST LINE ASSY	  	4
	 52088
	  	PROBE SUPPORT REAR	  	4
	 52089
	  	FREEZE TIP & EXHAUST ASSY	  	1
	 52235
	  	BOILER TIP ASSY 8-10MM	  	47
	 52239
	  	FRZE TIP & EXHAUST ASSY	  	1
	 52267
	  	FRZ TIP EXH & SUP ASY 15	  	3
	 52449
	  	FREEZE TIP & EXHST TUBE	  	1
	 52475
	  	BOILER TIP ASSY	  	44
	 52477
	  	FLT CRVX BOILER TIP & EXH	  	3
	 52478
	  	BOILER TIP ASSY WELD PER	  	23
	 52481
	  	BOILER TIP ASSY	  	9
	 52483
	  	BOILER TIP & EXHAUST	  	10
	 52507
	  	5MM + 20MM BOILER TIP	  	30
	 53270
	  	BOILER TIP & EXHAUST ASSY	  	2
	 53272
	  	BOILER TIP ASSY	  	50
	 30411-102
	  	SPRING PLUG-FAB MFG PG	  	160
	 30411-102
	  	SPRING PLUG-FAB MFG PG	  	13.332
	 31168-102
	  	DEL TUBE-FAB MFG P/PRINT	  	171
	 33225-202
	  	EXHAUST LINE CONN PLTA	  	40
	 33226-102
	  	DEL LINE CONN FAB	  	534
	 33226-202
	  	DEL LINE CONN PLTD	  	176
	 33231-202
	  	NOSE SECONDARY MACHINING	  	49
	 50421-202
	  	MALE CONN ASY-PLATED G	  	40
	 52070-202
	  	Y CONNECTOR PLATE P/PRINT	  	163
	 52074-202
	  	15MM BOILER TIP MACHINED	  	10
	 52090-202
	  	FRZE TIP & EXHAUST MACH	  	14
	 X1223-2
	  	Cardiac Boiler Tip	  	62
	 X1223-3
	  	5MM + 20MM BOILER TIP	  	10
	 X1223-5
	  	ADAPTER SCREW BOILER	  	18
	 X1223-7
	  	BOILER TIP & EXHAUST SUB-	  	9
	 X1370-3
	  	BOILER TIP/EXH.	  	1
	 X1374-3
	  	BOILER TIP ASSY.	  	1
	 X1413-4
	  	DELIVERY TUBE	  	2
	 X1447-3
	  	BOILER TIP & EXHAUST ASSY	  	1
	 X1474-2
	  	3x20mm CARDIAC PROBE	  	1

 Schedule D 
 Assigned Warranties 
 None listed, but to the extent assignable will be assigned. 

 Schedule E 
 Transferable Approvals 
 None 

 Schedule G 
 Console Delivery 
  

					
	 Console Type
	 	 Number of Consoles
	 	 Delivery Date*

	 CCS-200
	 	5	 	September 1, 2007
	 CCS-200
	 	8	 	October 1, 2007
	 CCS-200
	 	5	 	November 1, 2007
	 CCS-200
	 	5	 	December 1, 2007

	*	Within 5 days of the date indicated 

 Schedule H 
 Probe Delivery 
  

					
	 Probe Type
	 	 Number of Probes
	 	 Delivery Date1

	3011	 	10	 	September 1, 2007
	3011	 	10	 	October 1, 2007
	3011	 	10	 	November 1, 2007
	3011	 	10	 	December 1, 2007

	 1
	 Within 5 days of the date indicated 

 Exhibit 1 
 Promissory Note 

 PROMISSORY NOTE 
  

			
		 	PROMISSORY NOTE (“Note”), dated as of August 7, 2007, from AtriCure, Inc., a Delaware corporation, (“Maker”) to CooperSurgical, Inc., a Delaware corporation
(“Holder”)

 New York, New York 
 $417,292 
 This Note is delivered pursuant to a Bill of Sale and Assignment Agreement, dated as of the date hereof, between Maker
and Holder (the “Bill of Sale”). 
 1. Defined Terms. Capitalized terms used but not otherwise defined herein have the
meanings given to them in the Bill of Sale. 
 2. Promise to Pay. For value received, Maker promises to pay to the order of the
Holder, on the third Business Day following the Manufacturing Termination Date (such third Business Day being the “Maturity Date”) the principal sum of Four Hundred and Seventeen Thousand Two Hundred and Ninety Two and 00/100 ($417,292)
Dollars (the “Principal”) plus interest as provided below. In the event that Maker shall default under this Note, Maker shall also pay to Holder any and all fees and costs (including without limitation, reasonable attorneys’ fees and
disbursements whether for internal or outside counsel) the Holder incurs, after default, in order to collect any amount due under this Note (“Expenses”). 
 3. Interest. 
 (a) The unpaid Principal balance of this Note shall bear interest calculated on the
basis of a 360-day year for the actual number of days of each year (365 or 366) from and including the date of this Note to the date all amounts hereunder are paid in full at an annual rate of 5% compounded annually. 
 (b) In no event shall the interest rate charged pursuant to the terms of this Note exceed the highest rate permissible under the law of the State of New
York. In the event that Holder, through inadvertence or otherwise, has received payments hereunder characterized as interest which, if so treated, would result in interest charges in excess of the highest rate permitted under applicable law, such
payments, to the extent they result in such excess, shall be deemed to have been payments on account of the principal of this Note. 
 4.
Default Rate. If Maker fails to pay when due any amount under this Note, such amount shall bear interest at the rate of twelve (12%) percent per annum on the amount overdue until such amount is paid in full. 

 5. Repayment. Maker shall pay all amounts hereunder in immediately available United States funds.
Interest will continue to accrue until payment is actually received. Payments may be applied in any order in the sole discretion of the Holder but prior to default shall be applied first to past due interest, then Expenses, then to current interest,
and last to principal. 
 6. Prepayment. Maker may prepay this Note in whole only (and not in part) with interest to the date of
prepayment at any time upon two (2) business days’ written notice to the Holder. 
 7. Governing Law, Etc. 

(a) All questions concerning the construction, interpretation and validity of this Note shall be governed by and construed and enforced in accordance
with the domestic laws of the State of New York, without giving effect to any choice or conflict of law provision or rule (whether in the State of New York or any other jurisdiction) that would cause the application of the laws of any jurisdiction
other than the State of New York. In furtherance of the foregoing, the internal law of the State of New York will control the interpretation and construction of this Note, even if under such jurisdiction’s choice of law or conflict of law
analysis, the substantive law of some other jurisdiction would ordinarily or necessarily apply. 
 (b) BECAUSE DISPUTES ARISING IN CONNECTION
WITH COMPLEX FINANCIAL TRANSACTIONS ARE MOST QUICKLY AND ECONOMICALLY RESOLVED BY AN EXPERIENCED AND EXPERT PERSON AND THE PARTIES WISH APPLICABLE LAWS TO APPLY (RATHER THAN ARBITRATION RULES), THE MAKER AND HOLDER DESIRE THAT DISPUTES UNDER THIS
NOTE BE RESOLVED BY A JUDGE APPLYING SUCH APPLICABLE LAWS. THEREFORE, TO ACHIEVE THE BEST COMBINATION OF THE BENEFITS OF THE JUDICIAL SYSTEM, THE MAKER HERETO IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, SUIT OR PROCEEDING BASED UPON
OR ARISING OUT OF THIS NOTE. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THIS NOTE, THE MAKER ACKNOWLEDGES THAT THIS WAIVER IS A MATERIAL INDUCEMENT FOR THE
HOLDER TO ACCEPT THIS NOTE. THE MAKER PARTY HAS REVIEWED THIS WAIVER WITH ITS RESPECTIVE LEGAL COUNSEL, AND KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH SUCH LEGAL COUNSEL. IN THE EVENT OF LITIGATION, THIS NOTE
MAY BE FILED AS A WRITTEN CONSENT TO A TRIAL BY THE COURT. 
 (c) THE MAKER IRREVOCABLY AND UNCONDITIONALLY AGREES THAT PROCESS MAY BE SERVED
UPON IT BY CERTIFIED MAIL, RETURN RECEIPT REQUESTED OR REPUTABLE OVERNIGHT COURIER (SUCH AS FEDERAL EXPRESS), ADDRESSED AS MORE GENERALLY PROVIDED IN SECTION 9 HEREOF, AND CONSENTS TO THE EXERCISE OF JURISDICTION OVER IT AND ITS PROPERTIES BY
THE STATE AND FEDERAL COURTS LOCATED IN NEW YORK COUNTY WITH RESPECT TO ANY ACTION, SUIT OR PROCEEDING ARISING OUT OF OR IN 

 
CONNECTION WITH THIS NOTE OR THE ENFORCEMENT OF ANY RIGHTS UNDER THIS NOTE. SUCH SERVICE OF PROCESS SHALL BE DEEMED COMPLETE WHEN THE NOTICE CONTEMPLATED
HEREBY IS DEEMED DELIVERED UNDER SECTION 9 HEREIN. 
 8. Successors and Assigns. The terms of this Note apply to, inure to the
benefit of the Holder and its successors and assigns, and binds the Maker and its successors and assigns. 
 9. Notices. Any notice or
other communication required or permitted to be delivered to any party under this Note shall be in writing and shall be deemed properly delivered, given and received, if delivered during business hours on a Business Day, when delivered (by hand, by
registered mail, by courier or express delivery service or by facsimile) to the address or facsimile telephone number set forth beneath the name of such party below (or to such other address or facsimile telephone number as such party shall have
specified in a written notice given to the other party hereto) or, if not delivered during business hours on a Business Day, on the next succeeding Business Day: 
  

			
		 	 (A)   if to Cooper, to:

		
		 	 CooperSurgical, Inc.

		 	 95 Corporate Drive

		 	 Trumbull, Connecticut 06611

		 	 Attention: Nicholas Pichotta, CEO

		 	 Telephone: 203-601-5200

		 	 Facsimile: 203-601-1008

		 	 E-mail: jennifer.kropitis@coopersurgical.com
                     and
 nicholas.pichotta@coopersurgical.com

		
		 	 with copies to:

		
		 	 Carter Ledyard & Milburn LLP

		 	 2 Wall Street
 New York, New York 10005-2072
 Attention: David I. Karabell, Esq.

		 	 Telephone: 212-732-3200

		 	 Facsimile: 212-732-3232

		 	 E-mail: karabell@clm.com

		
		 	 (B)   if to AtriCure, to:

		
		 	 AtriCure, Inc.

		 	 6033 Schumacher Park Drive

		 	 West Chester, OH 45069

		 	 Attention: David J. Drachman, President

		 	 Telephone: 513-755-4100

		 	 Facsimile:
 E-mail: ddrachman@atricure.com

			
		 	 with a copies to:
  

		 	 Epstein Becker & Green, P.C.
 250 Park Avenue

 New York, New York 10177

		 	 Attention: Theodore Polin, Esq.
 Telephone: 212-351-4522

		 	Facsimile: 212-878-8616
		 	E-mail: tpolin@ebglaw.com

 All such notices and other communications shall be deemed to have been delivered and received
(i) in the case of personal delivery or delivery by telecopy or e-mail, on the date of such delivery if delivered during business hours on a Business Day or, if not delivered during business hours on a Business Day, the first Business Day
thereafter, (ii) in the case of delivery by nationally-recognized, overnight courier, on the Business Day following dispatch, and (iii) in the case of mailing, on the third Business Day following such mailing. 
 10. Headings. The captions set forth in this Note are for convenience only and shall not be considered as part of this Note or as in any way
limiting or amplifying the terms and provisions hereof. 
 11. Miscellaneous. Each provision of this Note shall survive until all
amounts due are paid to the Holder’s satisfaction, shall be interpreted as consistent with existing law and shall be deemed amended to the extent necessary to comply with any conflicting law. If a court deems any provision invalid, the
remainder of the Note shall remain in effect. Singular number includes plural and neuter gender includes masculine and feminine as appropriate. 
 [Signature page follows] 

 IN WITNESS WHEREOF, Maker has executed this Note as of the date first written above. 
  

			
	ATRICURE, INC.
		
	By:	 	 /s/ Julie A. Piton

	Name:	 	Julie A. Piton
	Title:	 	Vice- President and Chief Financial Officer

 Exhibit 2 
 Non-Competition Agreement 

 NONCOMPETITION AGREEMENT dated as of August 7, 2007 between COOPERSURGICAL, INC., a Delaware
corporation (“Cooper”) and ATRICURE, INC., a Delaware corporation (“AtriCure”). 
 Reference is made to the Bill of Sale and Assignment Agreement, dated as of the date of this Agreement (the “Bill of Sale”), between Cooper and AtriCure. Pursuant to the Bill of Sale, AtriCure is
acquiring the Frigitronics® CCS-200 product line for use in cardiovascular cryosurgery (the “Product Line”).
Cooper is retaining several related, but distinct, product lines. A portion of the purchase price under the Bill of Sale is evidenced by the promissory note of AtriCure in the amount of $417,292 payable to Cooper (the “Note”). This
Agreement is being entered into pursuant to the Bill of Sale. 
 In consideration of AtriCure purchasing the Purchased Assets under
the Bill of Sale and in order to prevent Cooper from being economically harmed by a loss of the goodwill associated with its ophthalmic cryosurgery products and gynecological cryosurgery products (“Cooper Products”), and to prevent
AtriCure from being economically harmed by a loss of goodwill associated with the Product Line, the parties hereto have agreed not to compete with each other or their respective Affiliates under the conditions set forth in this Agreement.

 ACCORDINGLY, in consideration of the good and valuable consideration which the parties hereto acknowledge, the parties hereto hereby agree
as follows: 
 Section 1. Certain Defined Terms. 
 (a) Capitalized terms used but not otherwise defined herein have the meanings set forth in the Bill of Sale. 
 (b) The term “Business Day” means any day that is not a Saturday, Sunday or a day on which banking institutions in New York, New York are not required to be open. 
 (c) The term “Business Group” means, in the case of Cooper, Cooper and its Affiliates, and in the case of AtriCure, AtriCure and its
Affiliates. 
 Section 2. Non-competition and Non-solicitation. 
 (a) Except as otherwise provided in the Bill of Sale, during the Cooper Non-Compete Period, Cooper shall not directly or indirectly through another
Person, including an Affiliate or by way of an ownership interest in another Person exceeding 10% of all ownership interests in such Person, or as a partner or joint venturer, sell, distribute, manufacture, advertise or promote (or assist any Person
engaging in any of the foregoing) cryosurgical products intended for use in cardiovascular cryosurgery within any Restricted Territory (as defined below) 
 (b) During the AtriCure Non-Compete Period, AtriCure shall not directly or indirectly through another Person, including an Affiliate or by way of an ownership interest in 

 
another Person exceeding 10% of all ownership interests in such Person, or as a partner or joint venturer, sell, distribute, manufacture, advertise or
promote (or assist any Person including any of the foregoing) cryosurgical products intended for ophthalmic or gynecological cryosurgery within any Restricted Territory (as defined below). 
 (c) As used in this Agreement, the term “Restricted Territory” means the entire world. 
 (d) As used in this Agreement, (i) the term “AtriCure Non-Compete Period” means the period beginning on the date of this Agreement
and ending on the eighth anniversary of the date of this Agreement and (ii) the term “Cooper Non-Compete Period” means the period beginning on the date of this Agreement and ending on the earlier of (A) the date that
AtriCure fails to pay Cooper when due amounts due to be paid under the Note and (B) the eighth anniversary of the date of this Agreement. 
 (e) During the period beginning on the date of this Agreement and ending on the second anniversary of the date of this Agreement, no party hereto shall directly, or indirectly through another Person, (i) solicit any employee of the
other party hereto or its Business Group to leave the employ of such party or any of its Business Group, or in any way interfere with the relationship between the party or any of its Business Group, on the one hand, and any employee thereof, on the
other hand; provided, however, that the general solicitation of third parties through the use of means generally available to the public, including the placement of advertisements in the newspaper, shall not be deemed to violate this
clause (i) or (ii) hire any individual who was an employee of such party until two (2) months after such individual’s employment relationship with that party or any of its Business Group has terminated. 
 (f) During the period beginning on the date of this Agreement and ending on the second anniversary of the date of this Agreement, no party hereto shall,
directly, or indirectly through another Person, induce or attempt to induce any customer, supplier, consultant, licensee or other business relation of the other party or any of its Business Group to cease doing business with the other party or any
of its Business Group, or in any way interfere with the relationship between any such customer, supplier, consultant, licensee or business relation, on the one hand, and the other party or any of its Business Group, on the other hand. 
 Section 3. Representations and Warranties. 
 (a) Cooper hereby represents and warrants to AtriCure that (i) Cooper has all requisite corporate power and authority to enter into this Agreement and to perform its obligations hereunder, (ii) this
Agreement has been duly and validly authorized by all necessary corporate action on the part of Cooper, and (iii) upon the execution and delivery of this Agreement by Cooper and AtriCure, this Agreement will be a valid and binding obligation of
Cooper. 
 (b) AtriCure hereby represents and warrants to Cooper that (i) AtriCure has all requisite corporate power and authority to
enter into this Agreement and to perform its obligations hereunder, (ii) this Agreement has been duly and validly authorized by all necessary corporate action on the part of AtriCure, and (iii) upon the execution and delivery of this
Agreement by Cooper and AtriCure, this Agreement will be a valid and binding obligation of AtriCure. 

 Section 4. Enforcement. 
 (a) Because the relationship between Cooper and AtriCure is unique, money damages, although recoverable, would not be a fully adequate remedy for any
breach of this Agreement. Therefore, in the event of a breach or threatened breach by a party to this Agreement, the other party hereto (the “Enforcing Party”) may apply to any court of competent jurisdiction for specific performance
and/or injunctive or other relief in order to enforce, or prevent any violations of, the provisions hereof (without posting a bond or other security) in addition to other rights and remedies existing in its favor, including money damages such as
requiring the other party hereto to account for and pay over to the Enforcing Party all compensation, profits, moneys, accruals, increments or other benefits derived or received as a direct result of any transactions constituting a breach of the
covenants contained herein. 
 (b) The prevailing party in any legal action arising out of or relating to this Agreement shall be entitled to
its reasonable attorneys’ fees and court costs. 
 Section 5. General Provisions. 
 (a) Severability. It is the desire and intent of the parties hereto that the provisions of this Agreement be enforced to the fullest extent
permissible under the laws and public policies applied in each jurisdiction in which enforcement is sought. Accordingly, if any particular provision of this Agreement shall be adjudicated by a court of competent jurisdiction to be invalid,
prohibited or unenforceable for any reason, such provision, as to such jurisdiction, shall be ineffective, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability of this Agreement or affecting the
validity or enforceability of such provision in any other jurisdiction. Notwithstanding the foregoing, if such provision could be more narrowly drawn so as not to be invalid, prohibited or unenforceable in such jurisdiction, it shall, as to such
jurisdiction, be so narrowly drawn, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability of such provision in any other jurisdiction. 
 (b) Complete Agreement. This Noncompetition Agreement and the Bill of Sale together constitute the entire agreement between the parties hereto
with respect to the subject matter hereof and supersede and preempt any prior understandings, agreements or representations by or between the parties, written or oral, which may have related to the subject matter hereof in any way. 
 (c) Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors
and assigns. 
 (d) Governing Law. This Agreement will be governed by and construed in accordance with the domestic laws of the State
of New York, without giving effect to any choice of law or conflicting provision or rule (whether of the State of New York or any other jurisdiction), that would cause the laws of any jurisdiction other than the state of New York to be applied. In
furtherance of the foregoing, the internal law of the State of New York will control the interpretation and construction of this Agreement, even if under such jurisdiction’s choice of law or conflict of law analysis, the substantive law of some
other jurisdiction would ordinarily apply. 

 (e) Waiver of Jury Trial. 
 (i) BECAUSE DISPUTES ARISING IN CONNECTION WITH COMPLEX FINANCIAL TRANSACTIONS ARE MOST QUICKLY AND ECONOMICALLY RESOLVED BY AN
EXPERIENCED AND EXPERT PERSON AND THE PARTIES WISH APPLICABLE LAWS TO APPLY (RATHER THAN ARBITRATION RULES), THE PARTIES DESIRE THAT THEIR DISPUTES BE RESOLVED BY A JUDGE APPLYING SUCH APPLICABLE LAWS. THEREFORE, TO ACHIEVE THE BEST COMBINATION OF
THE BENEFITS OF THE JUDICIAL SYSTEM, EACH PARTY HERETO IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, SUIT OR PROCEEDING BASED UPON OR ARISING OUT OF THIS AGREEMENT OR ANY DEALINGS BETWEEN THE PARTIES HERETO RELATING TO THE SUBJECT
MATTER HEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS AGREEMENT, INCLUDING, CONTRACT CLAIMS, TORT CLAIMS, BREACH OF DUTY
CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. EACH PARTY HERETO ACKNOWLEDGES THAT THIS WAIVER IS A MATERIAL INDUCEMENT TO ENTER INTO THIS AGREEMENT. EACH PARTY HAS REVIEWED THIS WAIVER WITH ITS RESPECTIVE LEGAL COUNSEL, AND KNOWINGLY AND
VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH SUCH LEGAL COUNSEL. IN THE EVENT OF LITIGATION, THIS AGREEMENT MAY BE FILED AS A WRITTEN CONSENT TO A TRIAL BY THE COURT. 
 (ii) EACH PARTY IRREVOCABLY AND UNCONDITIONALLY AGREES THAT PROCESS MAY BE SERVED UPON IT BY CERTIFIED MAIL, RETURN RECEIPT REQUESTED OR
REPUTABLE OVERNIGHT COURIER (SUCH AS FEDERAL EXPRESS), ADDRESSED AS MORE GENERALLY PROVIDED IN SECTION 5(k) HEREOF, AND CONSENTS TO THE EXERCISE OF JURISDICTION OVER IT AND ITS PROPERTIES BY THE STATE AND FEDERAL COURTS LOCATED IN THE COUNTY
OF NEW YORK WITH RESPECT TO ANY ACTION, SUIT OR PROCEEDING ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THE ENFORCEMENT OF ANY RIGHTS UNDER THIS AGREEMENT. SUCH SERVICE OF PROCESS SHALL BE DEEMED
COMPLETE WHEN THE NOTICE CONTEMPLATED HEREBY IS DEEMED DELIVERED UNDER SECTION 5(k) HEREIN. 
 (f) Amendment and Waiver. The
provisions of this Agreement may be amended and waived only with the written consent of both parties hereto, and no course of conduct or failure or delay in enforcing the provisions of this Agreement shall affect the validity, binding effect or
enforceability of this Agreement or any provision hereof. 
 (g) Headings. The section headings contained in this Agreement are
inserted for convenience only and shall not affect in any way the meaning or interpretation of this Agreement. 

 (h) Counterparts. This Agreement may be executed in two or more counterparts, each of which shall
be deemed an original and all of which together shall constitute one and the same instrument. Facsimile or electronic counterpart signatures to this Agreement shall be acceptable and binding. 
 (i) Survival of Representations and Warranties. All representations and warranties contained herein shall survive the consummation of the
transactions contemplated hereby and by the Bill of Sale. 
 (j) Construction. 
 (i) For purposes of this Agreement, whenever the context requires: the singular number shall include the plural, and vice versa; the
masculine gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter genders; and the neuter gender shall include the masculine and feminine genders. 
 (ii) Any rule of construction to the effect that ambiguities are to be resolved against the drafting party shall not be applied in the
construction or interpretation of this Agreement. 
 (iii) As used in this Agreement, the words “include” and
“including,” and variations thereof, shall not be deemed to be terms of limitation, but rather shall be deemed to be followed by the words “without limitation.” 
 (k) Notices. Any notice or other communication required or permitted to be delivered to any party under this Agreement shall be in writing and
shall be deemed properly delivered, given and received, if delivered during business hours on a Business Day, when delivered (by hand, by registered mail, by courier or express delivery service or by facsimile) to the address or facsimile telephone
number set forth beneath the name of such party below (or to such other address or facsimile telephone number as such party shall have specified in a written notice given to the other party hereto) or, if not delivered during business hours on a
Business Day, on the next succeeding Business Day: 
  

	 	(A)	if to Cooper, to: 

 CooperSurgical, Inc. 
 95 Corporate Drive 
 Trumbull, Connecticut
06611 
 Attention: Nicholas Pichotta, CEO 
 Telephone: 203-601-5200 
 Facsimile: 203-601-1008 
 E-mail: jennifer.kropitis@coopersurgical.com 
                     and 
 nicholas.pichotta@coopersurgical.com 

 with copies to: 
 Carter Ledyard & Milburn LLP 
 2 Wall Street 
 New York, New York 10005-2072 
 Attention:
David I. Karabell, Esq. 
 Telephone: 212-732-3200 
 Facsimile: 212-732-3232 
 E-mail: karabell@clm.com 
  

	 	(B)	if to AtriCure, to: 

 AtriCure, Inc. 
 6033 Schumacher Park Drive 
 West Chester,
OH 45069 
 Attention: David J. Drachman 
 Telephone: 513-755-4100 
 Facsimile: 
 E-mail: ddrachman@atricure.com 
 with a copies to: 
 Epstein Becker & Green, P.C. 
 250 Park Avenue 
 New York, New York 10177

 Attention: Theodore Polin, Esq. 
 Telephone: 212-351-4522 
 Facsimile: 212-878-8616 
 E-mail: tpolin@ebglaw.com 
 All such notices and other communications shall be deemed to have been
delivered and received (i) in the case of personal delivery or delivery by telecopy or e-mail, on the date of such delivery if delivered during business hours on a Business Day or, if not delivered during business hours on a Business Day, the
first Business Day thereafter, (ii) in the case of delivery by nationally-recognized, overnight courier, on the Business Day following dispatch, and (iii) in the case of mailing, on the third Business Day following such mailing.

 [Signature Page Follows] 

 IN WITNESS WHEREOF, each of the parties hereto has duly executed this Noncompetition Agreement as of the
date first written above. 
  

			
	COOPERSURGICAL, INC.
		
	By:	 	 /s/ Nicholas J. Pichotta

	Name:	 	Nicholas J. Pichotta
	Title:	 	President and Chief Executive Officer
	
	ATRICURE, INC.
		
	By:	 	 /s/ David J. Drachman

	Name:	 	David J. Drachman
	Title:	 	President and Chief Executive Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00127-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00127-of-00352.parquet"}]]